{"meta":{"query_hash":"df1fdcca5102","filters":{"venue":"Vascular Health and Risk Management"},"cohort_total":59,"direct_labels_cover":1,"predictions_cover":59,"exported":59,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/df1fdcca5102","api":"https://metacan.xera.ac/api/v1/cohort?venue=Vascular+Health+and+Risk+Management"},"results":[{"id":"W1707073606","doi":"10.2147/vhrm.s63060","title":"Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism","year":2015,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Apixaban; Rivaroxaban; Edoxaban; Dabigatran; Warfarin; Intensive care medicine; Vitamin K antagonist; Deep vein; Heparin; Ximelagatran; Pulmonary embolism; Direct thrombin inhibitor; Thrombosis; Atrial fibrillation; Surgery; Internal medicine","score_opus":0.041651420892191426,"score_gpt":0.34601265207517806,"score_spread":0.30436123118298664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1707073606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020719606,0.9941732,0.00041163413,0.0009520575,0.00016251273,0.000009366734,0.000034576024,0.000007822603,0.0021768408],"genre_scores_gemma":[0.009257681,0.9880079,0.0007643733,0.0006572295,0.00042372828,0.0000133846515,0.00006883986,0.0000028789468,0.0008039063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996105,0.00009446284,0.00008394987,0.0000449925,0.00014527235,0.000020958885],"domain_scores_gemma":[0.99959797,0.00017131193,0.000073696574,0.00000875532,0.00012397746,0.000024398414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007714355,0.00032310793,0.00046839216,0.0011802949,0.00014882641,0.0007522968,0.00028890956,0.0005188262,0.0012348326],"category_scores_gemma":[0.00078191835,0.00012014346,0.00046148177,0.00079248624,0.00023313252,0.000686954,0.00030600085,0.0011933333,0.0005467242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036929856,0.00016677783,0.0017494168,0.010088313,0.00021128726,0.0006466552,0.0001559961,0.0007133727,0.0061765853,0.008049918,0.013093201,0.95857906],"study_design_scores_gemma":[0.00008953085,0.0018613345,0.006585042,0.0043222425,0.0005373711,0.008882777,0.00013146861,0.0008655779,0.0074974988,0.0037926366,0.9653638,0.00007071957],"about_ca_topic_score_codex":0.000589984,"about_ca_topic_score_gemma":0.0006928421,"teacher_disagreement_score":0.0012348326,"about_ca_system_score_codex":0.00037458006,"about_ca_system_score_gemma":0.0005615111,"threshold_uncertainty_score":0.0041309},"labels":[],"label_agreement":null},{"id":"W1810783489","doi":"10.2147/vhrm.s3512","title":"Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: Current understandings and future research priorities","year":2008,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cholesterol; Dietary fiber; Guar gum; Bile acid; Sterol; Metabolism; Medicine; Lipid metabolism; Biochemistry; Biology; Food science","score_opus":0.07922894444813684,"score_gpt":0.37800541070263327,"score_spread":0.29877646625449644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1810783489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000079092395,0.9990916,0.000078156256,0.00022433918,0.000115205796,0.0000022178394,0.0000049786536,0.0000037911957,0.00040066193],"genre_scores_gemma":[0.00030618734,0.99898964,0.00015456502,0.00011538634,0.00012715434,0.000003850997,0.000009124848,6.718542e-7,0.00029344688],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979967,0.00003971485,0.000033779535,0.000038622315,0.00006573562,0.000022532622],"domain_scores_gemma":[0.9995146,0.00025960017,0.0000613084,0.000016162958,0.00009707833,0.000051192805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010733242,0.0010540797,0.0024266532,0.0023394232,0.0003703866,0.0015119748,0.001120228,0.0019378113,0.0039020476],"category_scores_gemma":[0.0007648781,0.00035138283,0.0005922966,0.0029997646,0.0009390765,0.002831334,0.0008215698,0.0021987222,0.0026017756],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015066928,0.00013247976,0.00020189908,0.014129564,0.000077603094,0.00038046273,0.000082909246,0.0002923509,0.0027365638,0.0039504953,0.014630223,0.96323484],"study_design_scores_gemma":[0.00003938906,0.00017253973,0.0012659836,0.004713833,0.00013933345,0.0018047371,0.00018902619,0.0001453569,0.0007229628,0.004470933,0.98630327,0.00003267078],"about_ca_topic_score_codex":0.0010506681,"about_ca_topic_score_gemma":0.0020042066,"teacher_disagreement_score":0.0039020476,"about_ca_system_score_codex":0.0006770845,"about_ca_system_score_gemma":0.001136962,"threshold_uncertainty_score":0.013053656},"labels":[],"label_agreement":null},{"id":"W1824620580","doi":"10.2147/vhrm.s3467","title":"Update on the use of Trandolapril in the management of cardiovascular disorders","year":2008,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Trandolapril; Medicine; Cardiology; Internal medicine; Heart failure; Coronary artery disease; Angiotensin-converting enzyme; Diabetes mellitus; ACE inhibitor; Myocardial infarction; Nephropathy; Blood pressure; Endocrinology","score_opus":0.08125878746746061,"score_gpt":0.30186641646274665,"score_spread":0.22060762899528602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1824620580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011856273,0.9977028,0.000084738786,0.000382134,0.00043081582,0.0000114595005,0.000039559203,0.000007989528,0.0012220058],"genre_scores_gemma":[0.00039847023,0.9981919,0.00027869034,0.00035832988,0.00023553753,0.00000889212,0.000050604423,0.0000015218093,0.0004760326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995863,0.00008916009,0.00011052207,0.000039056053,0.00015490354,0.000020018239],"domain_scores_gemma":[0.99906045,0.00046156117,0.00017151822,0.000020276904,0.00023610628,0.000050116945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007729506,0.0008055718,0.0015243109,0.0039035603,0.00027601523,0.0008903816,0.0011256792,0.0011524217,0.0056543346],"category_scores_gemma":[0.0015481949,0.00031827405,0.0008475068,0.0043111066,0.00031617997,0.001468038,0.00057372026,0.0015018885,0.0020603999],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009233776,0.00008045812,0.00020771123,0.04186237,0.00023803787,0.00038762714,0.000098717646,0.00023707344,0.000819502,0.0013400246,0.08280586,0.8718303],"study_design_scores_gemma":[0.000035575453,0.00009028241,0.0015501197,0.014539049,0.00045674253,0.002046846,0.00006794219,0.00008214156,0.00016463245,0.0006570359,0.9802916,0.000018090921],"about_ca_topic_score_codex":0.0022187626,"about_ca_topic_score_gemma":0.005892166,"teacher_disagreement_score":0.0056543346,"about_ca_system_score_codex":0.00063296495,"about_ca_system_score_gemma":0.0013646797,"threshold_uncertainty_score":0.018915653},"labels":[],"label_agreement":null},{"id":"W1827812019","doi":"10.2147/vhrm.s2132","title":"Management of venous thromboembolism in patients with cancer: role of dalteparin","year":2008,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Medicine; Vitamin K antagonist; Venous thromboembolism; Cancer; Anticoagulant; Intensive care medicine; Low molecular weight heparin; Heparin; Anticoagulant therapy; Internal medicine; Thrombosis; Warfarin; Atrial fibrillation","score_opus":0.011583499158459248,"score_gpt":0.28666112429001134,"score_spread":0.2750776251315521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1827812019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020523283,0.99883443,0.000091745984,0.00029341638,0.00006463027,0.000002724323,0.000005159075,0.000004202575,0.0004983519],"genre_scores_gemma":[0.0011960166,0.99808264,0.0002531146,0.00012787285,0.0000857703,0.000004206883,0.000009556891,5.9642747e-7,0.00024028716],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998523,0.00003152373,0.00002891313,0.000021652539,0.000055691937,0.000009914616],"domain_scores_gemma":[0.99979967,0.00009420863,0.000044249293,0.000004266187,0.000040772367,0.00001694534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035811678,0.0005197102,0.0011116454,0.0013221464,0.00017443286,0.0005318236,0.0006013239,0.000774151,0.0013643255],"category_scores_gemma":[0.00059633906,0.00012555139,0.00035526618,0.0012628608,0.00025869734,0.0006823995,0.00031451383,0.0012281898,0.00082750653],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059024802,0.000081539634,0.00037621797,0.008721029,0.00007943905,0.0003200017,0.000048852613,0.00022086593,0.0009056626,0.0009488592,0.010029481,0.978209],"study_design_scores_gemma":[0.000081280195,0.00038001806,0.004785725,0.007942218,0.000327682,0.010200934,0.00016536436,0.00032516886,0.0012811412,0.0020610797,0.97241646,0.000032928605],"about_ca_topic_score_codex":0.0010217952,"about_ca_topic_score_gemma":0.0016105529,"teacher_disagreement_score":0.0013643255,"about_ca_system_score_codex":0.0003962551,"about_ca_system_score_gemma":0.00059838436,"threshold_uncertainty_score":0.0045641065},"labels":[],"label_agreement":null},{"id":"W1886441546","doi":"10.2147/vhrm.s8222","title":"Effectiveness of percutaneous laser revascularization therapy for refractory angina","year":2010,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Pain Management and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Public Health Ontario; McMaster University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Angina; Canadian Cardiovascular Society; Internal medicine; Revascularization; Coronary artery disease; Cardiology; Quality of life (healthcare); Percutaneous; Meta-analysis; Adverse effect; Percutaneous coronary intervention; Physical therapy; Myocardial infarction","score_opus":0.018540320182232697,"score_gpt":0.32080318466268715,"score_spread":0.3022628644804545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1886441546","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1995332,0.7912804,0.00097559876,0.0014290278,0.00073443295,0.00039416685,0.00062027114,0.00006993447,0.004962995],"genre_scores_gemma":[0.9370601,0.05889549,0.00093587843,0.0014044369,0.000517433,0.00023678411,0.00037892486,0.000019384148,0.00055165484],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.99395317,0.004067567,0.00063993986,0.0005680447,0.00062787894,0.00014335613],"domain_scores_gemma":[0.99321693,0.0051840195,0.0010235743,0.00019475991,0.00019148077,0.000189305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067560165,0.00071280566,0.0049208035,0.0012108543,0.00027824525,0.0013565161,0.00083066267,0.0015219649,0.0022954666],"category_scores_gemma":[0.012076122,0.00042170612,0.012137418,0.00085323106,0.0004951325,0.0008290854,0.000574856,0.0019146685,0.0001740791],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21033955,0.0015260394,0.010307478,0.09153509,0.4317137,0.00033619438,0.00025351305,0.0041914512,0.004439995,0.0010681902,0.003276233,0.24101259],"study_design_scores_gemma":[0.13596348,0.051812273,0.07542865,0.019276254,0.6930418,0.0009719636,0.00030757597,0.00534318,0.002889226,0.004150372,0.010602309,0.00021293448],"about_ca_topic_score_codex":0.0020520505,"about_ca_topic_score_gemma":0.004219988,"teacher_disagreement_score":0.0067560165,"about_ca_system_score_codex":0.0011717315,"about_ca_system_score_gemma":0.000663834,"threshold_uncertainty_score":0.035729706},"labels":[],"label_agreement":null},{"id":"W1939039978","doi":"10.2147/vhrm.s3748","title":"Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience","year":2008,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Hospital Edmonton; University of Alberta Hospital","funders":"University of Alberta","keywords":"Medicine; Lipid profile; Cholesterol; Internal medicine; Medical record; Retrospective cohort study; Lipoprotein","score_opus":0.0219923866325342,"score_gpt":0.2726773774479245,"score_spread":0.25068499081539025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1939039978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911946,0.00016607891,0.000054224434,0.00019388724,0.000011973337,0.00002495529,0.00007384784,0.000006257091,0.00034928237],"genre_scores_gemma":[0.99859077,0.00034096127,0.00013859932,0.00020489708,0.000029448127,0.000023654811,0.0002268348,0.0000035315938,0.00044132926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988475,0.00022678342,0.00011358572,0.000090655296,0.00033775266,0.0003836711],"domain_scores_gemma":[0.9959189,0.00052056357,0.0010713141,0.0002000899,0.00055283005,0.0017363004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018234479,0.00028350495,0.00063058053,0.0007543492,0.0013042022,0.0011318944,0.0007273909,0.00102637,0.001174184],"category_scores_gemma":[0.004638983,0.00043526196,0.00063065597,0.0007793954,0.00050818897,0.0013281798,0.0013709592,0.0014047982,0.00038363758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033020653,0.002025401,0.9700217,0.00003508267,0.000060560265,0.0022436418,0.003658544,0.00006795526,0.0005797348,0.000028725566,0.0008003693,0.020148085],"study_design_scores_gemma":[0.0000612284,0.0027865882,0.98956126,0.00003172506,0.00003414298,0.0026772413,0.003218825,0.00020577584,0.00020144465,0.000021000364,0.0011609173,0.00003992541],"about_ca_topic_score_codex":0.008407056,"about_ca_topic_score_gemma":0.01406698,"teacher_disagreement_score":0.008407056,"about_ca_system_score_codex":0.0011368932,"about_ca_system_score_gemma":0.001319773,"threshold_uncertainty_score":0.016716242},"labels":[],"label_agreement":null},{"id":"W1960615162","doi":"10.2147/vhrm.s3810","title":"Effects of study design and trends for EVAR versus OSR","year":2008,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Aortic aneurysm repair treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Perioperative; Randomized controlled trial; Observational study; CINAHL; MEDLINE; Meta-analysis; Randomization; Surgery; Internal medicine; Psychological intervention","score_opus":0.04369874915387859,"score_gpt":0.3593300322659474,"score_spread":0.3156312831120688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1960615162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17771776,0.7765305,0.018652514,0.007081753,0.003113012,0.0034128195,0.008739347,0.00026166794,0.0044905976],"genre_scores_gemma":[0.952178,0.023643207,0.011215685,0.004483491,0.00091848173,0.0040426706,0.0023181865,0.00027264733,0.0009276934],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.69145364,0.18699749,0.0721376,0.024845807,0.021168552,0.0033968836],"domain_scores_gemma":[0.38137978,0.51608694,0.077300824,0.013380327,0.009850433,0.0020017587],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2632287,0.001483762,0.006589282,0.0045626387,0.0010470549,0.0056843627,0.003576559,0.0050208666,0.008205074],"category_scores_gemma":[0.46094772,0.001263888,0.02448606,0.008128164,0.0023826542,0.0054103113,0.002521665,0.002607991,0.00069195684],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060525585,0.0002684434,0.40910515,0.0978088,0.34833205,0.00055382197,0.0016815414,0.0009290344,0.0015573465,0.0027150377,0.003470047,0.07305314],"study_design_scores_gemma":[0.010885362,0.015056699,0.39646447,0.037456013,0.50252604,0.0018609135,0.0024308448,0.0031996092,0.003854566,0.009422893,0.016506871,0.0003357627],"about_ca_topic_score_codex":0.0020495718,"about_ca_topic_score_gemma":0.0032696147,"teacher_disagreement_score":0.7367713,"about_ca_system_score_codex":0.0027631342,"about_ca_system_score_gemma":0.0038800822,"threshold_uncertainty_score":0.9085702},"labels":[],"label_agreement":null},{"id":"W1984365947","doi":"10.2147/vhrm.2008.04.01.1","title":"Gadofosveset-enhanced magnetic resonance angiography","year":2008,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Magnetic resonance angiography; Radiology; Magnetic resonance imaging; Vascular disease; Angiography; Stenosis; Nuclear medicine; Surgery","score_opus":0.021559094900437194,"score_gpt":0.33884892968621055,"score_spread":0.3172898347857734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984365947","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002946321,0.99749184,0.00025758139,0.00014687494,0.00009197906,0.000007901551,0.000014030718,0.000012372751,0.0016829221],"genre_scores_gemma":[0.0015302357,0.99703777,0.00028915465,0.000121201316,0.00010930012,0.00000711495,0.000029448971,0.0000014637246,0.00087437005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987125,0.000021078926,0.000017309592,0.000025729409,0.000050941948,0.0000137529805],"domain_scores_gemma":[0.9998598,0.000047160484,0.000033572964,0.000005217753,0.000040100425,0.000014152234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003674806,0.00083053403,0.0014932035,0.002555709,0.00017808477,0.000697804,0.0007102604,0.00071697234,0.0031067408],"category_scores_gemma":[0.0004608547,0.00026922286,0.00045642923,0.0022542365,0.0003384526,0.00087463687,0.00041452356,0.0007606655,0.0031916788],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007396435,0.000069149835,0.00021314342,0.010832015,0.00007962552,0.00077760976,0.000034527257,0.00018392468,0.002917319,0.00087296753,0.01863259,0.96531314],"study_design_scores_gemma":[0.000044816476,0.0001853099,0.003314507,0.0037802856,0.00017386004,0.013305786,0.00006913782,0.00016135878,0.0023534617,0.0015121761,0.9750676,0.00003176867],"about_ca_topic_score_codex":0.00086488103,"about_ca_topic_score_gemma":0.0013814205,"teacher_disagreement_score":0.0031067408,"about_ca_system_score_codex":0.00038902098,"about_ca_system_score_gemma":0.0006300855,"threshold_uncertainty_score":0.010393083},"labels":[],"label_agreement":null},{"id":"W1987145604","doi":"10.2147/vhrm.2008.04.01.213","title":"Effect of short-term lycopene supplementation and postprandial dyslipidemia on plasma antioxidants and biomarkers of endothelial health in young, healthy individuals","year":2008,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"University of Waterloo; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Lycopene; Oxidative stress; Internal medicine; Medicine; Endocrinology; Malondialdehyde; Postprandial; Dyslipidemia; Nitric oxide; Antioxidant; Biochemistry; Chemistry; Obesity","score_opus":0.013477567764619074,"score_gpt":0.3068498764235746,"score_spread":0.2933723086589555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987145604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941313,0.0004488399,0.000029938014,0.000010233196,0.0000047904246,0.0000054632346,0.000024285802,0.0000015509161,0.00006181733],"genre_scores_gemma":[0.99894255,0.00028785,0.00022925825,0.000070555216,0.000011778496,0.000022288821,0.00009951959,0.0000016886041,0.00033446262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999039,0.000035363206,0.000009985129,0.000022851436,0.000014231426,0.0000136544195],"domain_scores_gemma":[0.99963176,0.00009001478,0.00009291325,0.000026733558,0.000030622534,0.00012787909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040285508,0.0002606008,0.0004821916,0.00014040164,0.00014942135,0.0002656585,0.00010216668,0.00042461776,0.00070302846],"category_scores_gemma":[0.00042291527,0.00019020356,0.00022930941,0.00009754215,0.00015233108,0.0001840348,0.00018507235,0.00035330467,0.00011626606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13975368,0.0070817485,0.45264578,0.0005155849,0.0013015115,0.0010399795,0.00058538426,0.00022236275,0.36063567,0.000081131955,0.0003695946,0.035767566],"study_design_scores_gemma":[0.00048921286,0.022763105,0.9702527,0.00001374078,0.00026658684,0.00034604874,0.00014021584,0.00021482597,0.0051612817,0.000029707979,0.00031470528,0.000007846048],"about_ca_topic_score_codex":0.0006007714,"about_ca_topic_score_gemma":0.0011400796,"teacher_disagreement_score":0.00070302846,"about_ca_system_score_codex":0.00010352022,"about_ca_system_score_gemma":0.00012605546,"threshold_uncertainty_score":0.00235188},"labels":[],"label_agreement":null},{"id":"W1999597525","doi":"10.2147/vhrm.1.1.29.58937","title":"Ongoing clinical trials of the pleiotropic effects of statins","year":2005,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Montreal Clinical Research Institute","funders":"AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Clinical trial; Tolerability; Statin; Stroke (engine); Internal medicine; Randomized controlled trial; Physical therapy; Disease; Atorvastatin; Bioinformatics; Intensive care medicine; Adverse effect","score_opus":0.08106946811989335,"score_gpt":0.43532799523453297,"score_spread":0.3542585271146396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999597525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09382375,0.87639606,0.0018521665,0.007839748,0.0012096645,0.011970461,0.0013030973,0.000041512503,0.005563496],"genre_scores_gemma":[0.46975514,0.4738562,0.011853817,0.012044099,0.006100717,0.022087863,0.0028532967,0.000034979203,0.0014139495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9087576,0.06377492,0.019954503,0.0015087585,0.00517788,0.0008263271],"domain_scores_gemma":[0.7335211,0.19449385,0.048428204,0.0048300116,0.016185459,0.0025414207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11577639,0.0007343713,0.0033833059,0.0021751276,0.0010199968,0.0035574227,0.001800542,0.004229874,0.005845836],"category_scores_gemma":[0.15669191,0.0005758527,0.0035981627,0.0047025774,0.0016795484,0.0030235024,0.0011065803,0.0022269886,0.00080317806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16493551,0.0030194926,0.033526603,0.3261036,0.02477955,0.0006946687,0.002235711,0.0006806209,0.0048343427,0.0023497,0.005638998,0.43120116],"study_design_scores_gemma":[0.24185227,0.12436164,0.106941,0.30911526,0.09341595,0.0018289563,0.0025974044,0.0008313449,0.007890985,0.007870923,0.10304917,0.0002450755],"about_ca_topic_score_codex":0.00033516283,"about_ca_topic_score_gemma":0.0010023013,"teacher_disagreement_score":0.11577639,"about_ca_system_score_codex":0.0016950227,"about_ca_system_score_gemma":0.0062304265,"threshold_uncertainty_score":0.6122914},"labels":[],"label_agreement":null},{"id":"W2007918875","doi":"10.2147/vhrm.2006.2.3.263","title":"Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Pharmacology; Cardiology; Physiology","score_opus":0.03961851808375531,"score_gpt":0.3338908191304285,"score_spread":0.2942723010466732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007918875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004459269,0.9985629,0.00007669407,0.00016570375,0.000057279663,0.000002502918,0.000013795068,0.0000047539684,0.0006704352],"genre_scores_gemma":[0.002107408,0.99723035,0.00009234013,0.00008011922,0.00006751697,0.0000032042158,0.0000140633265,5.909412e-7,0.00040437636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999244,0.000016557582,0.000013108974,0.000014407486,0.000023095667,0.000008319556],"domain_scores_gemma":[0.9998753,0.0000531362,0.000019516681,0.000004260939,0.000035389254,0.000012340717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002811875,0.00056609546,0.0012313566,0.0012588138,0.00019007247,0.0005531325,0.0005649051,0.00082029705,0.003531541],"category_scores_gemma":[0.00032723375,0.00012916727,0.0002601852,0.0015211804,0.00028445746,0.0007160399,0.00026812317,0.00050675956,0.001283108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019209314,0.00012362374,0.00072699744,0.023100678,0.00021688554,0.0006485525,0.0000638227,0.00022498952,0.0042036944,0.0012266375,0.0089860475,0.96028596],"study_design_scores_gemma":[0.00012318499,0.00059359253,0.017762559,0.009275013,0.0009507652,0.008040629,0.00038443485,0.00023607833,0.0043436545,0.003247416,0.95498604,0.0000565284],"about_ca_topic_score_codex":0.001355698,"about_ca_topic_score_gemma":0.0028287717,"teacher_disagreement_score":0.003531541,"about_ca_system_score_codex":0.00034999606,"about_ca_system_score_gemma":0.0005667671,"threshold_uncertainty_score":0.011814177},"labels":[],"label_agreement":null},{"id":"W2014343126","doi":"10.2147/vhrm.s11253","title":"Stentless aortic valve replacement: an update","year":2011,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aortic valve replacement; Stent; Regurgitation (circulation); Surgery; Aortic valve; Hemodynamics; Randomized controlled trial; Cardiology; Internal medicine; Stenosis","score_opus":0.03258200838865432,"score_gpt":0.37276786229015624,"score_spread":0.3401858539015019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014343126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036591082,0.99630034,0.00023801054,0.0010930739,0.0011015913,0.000004632623,0.000031749238,0.000015264484,0.00084933813],"genre_scores_gemma":[0.0014369439,0.9937649,0.00049321004,0.0010527926,0.0026872798,0.000008972887,0.000081765436,0.0000065398654,0.0004675728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995498,0.000066268374,0.00012130047,0.000081504964,0.0001536025,0.000027553833],"domain_scores_gemma":[0.9981066,0.0009464402,0.00023897224,0.000051942363,0.0004756643,0.00018044679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011440254,0.0007295947,0.0017637224,0.0022548554,0.0002798284,0.0015009285,0.0010417715,0.0015752683,0.0036718391],"category_scores_gemma":[0.0021737951,0.00038556816,0.0008714383,0.0016374245,0.0005511622,0.002130189,0.0006374995,0.0025203354,0.0018451464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015354183,0.00010425445,0.0008189315,0.0117970845,0.0001697138,0.00084478536,0.00007228296,0.00027407706,0.0008164801,0.0020467918,0.056628138,0.92627394],"study_design_scores_gemma":[0.00005955671,0.00027515748,0.0028028104,0.007960299,0.00040035517,0.011552199,0.00010059521,0.00026259967,0.0003396016,0.0014494617,0.97476065,0.000036796846],"about_ca_topic_score_codex":0.00066778174,"about_ca_topic_score_gemma":0.0014786356,"teacher_disagreement_score":0.0036718391,"about_ca_system_score_codex":0.0005741682,"about_ca_system_score_gemma":0.0010342101,"threshold_uncertainty_score":0.012283504},"labels":[],"label_agreement":null},{"id":"W2014582235","doi":"10.2147/vhrm.s63298","title":"XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation","year":2014,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bayer HealthCare","keywords":"Medicine; Atrial fibrillation; Rivaroxaban; Stroke (engine); Internal medicine; Cardiology; Intensive care medicine; Warfarin","score_opus":0.03365606308901662,"score_gpt":0.30872252529651045,"score_spread":0.2750664622074938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014582235","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023744287,0.0069992547,0.042904392,0.008184312,0.0086107,0.8895683,0.0050794706,0.00028554245,0.014623601],"genre_scores_gemma":[0.03578385,0.0021208487,0.06337885,0.008089387,0.0027104567,0.8830402,0.0013797369,0.00006346012,0.0034332678],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9129601,0.06361034,0.0063447296,0.005818496,0.008949124,0.0023170782],"domain_scores_gemma":[0.96889216,0.010698532,0.0031860964,0.006045538,0.0063623437,0.004815349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10505525,0.004455166,0.004642817,0.00280195,0.0039594145,0.0039757504,0.0046373517,0.0070999106,0.012411154],"category_scores_gemma":[0.054483287,0.003798914,0.0034211057,0.0030089812,0.0056091985,0.003064142,0.0036368887,0.008252722,0.008248782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3854274,0.047292452,0.05221486,0.020334287,0.0055429093,0.0043307967,0.0073986175,0.0045055,0.016741417,0.18494105,0.09046645,0.18080434],"study_design_scores_gemma":[0.29695082,0.10141933,0.033431586,0.00633888,0.0042419136,0.0020295484,0.0012803235,0.009985962,0.0049673747,0.056023132,0.48254302,0.0007881949],"about_ca_topic_score_codex":0.0011309884,"about_ca_topic_score_gemma":0.002115949,"teacher_disagreement_score":0.10505525,"about_ca_system_score_codex":0.0018766177,"about_ca_system_score_gemma":0.011764642,"threshold_uncertainty_score":0.55559194},"labels":[],"label_agreement":null},{"id":"W2019882954","doi":"10.2147/vhrm.1.1.41.58936","title":"New anticoagulants for the prevention and treatment of venous thromboembolism","year":2005,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Antithrombotic; Intensive care medicine; Venous thromboembolism; Anticoagulant; Anticoagulant therapy; Vitamin K antagonist; Vitamin k; Warfarin; Thrombosis; Surgery; Atrial fibrillation; Internal medicine","score_opus":0.052950610041974704,"score_gpt":0.36858380623860393,"score_spread":0.3156331961966292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019882954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000101481935,0.9979778,0.000121209305,0.00017167126,0.00016808147,0.000008778113,0.000011280041,0.000007181609,0.001432596],"genre_scores_gemma":[0.0005594462,0.99802446,0.000294393,0.00014081998,0.0001562721,0.000007646949,0.000026043661,0.0000010022916,0.00079000613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999696,0.000049533766,0.00004544806,0.00003624113,0.00015221314,0.000020694797],"domain_scores_gemma":[0.99962234,0.00014788145,0.00006882526,0.000013706028,0.000110649984,0.00003644578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006040372,0.000954032,0.0014539085,0.003279733,0.00032732738,0.00065836956,0.0007599917,0.00097484316,0.0060885176],"category_scores_gemma":[0.0007878397,0.00023019045,0.00053403096,0.0031635826,0.0004614655,0.0012175477,0.00048292775,0.0015260923,0.00340919],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058254445,0.00012436778,0.00020566983,0.016972996,0.0001197492,0.00024364478,0.00006280686,0.00021217745,0.0017487238,0.001947111,0.030983044,0.9473214],"study_design_scores_gemma":[0.000046793193,0.000099991164,0.0013385038,0.005044454,0.00017023092,0.0024647466,0.00006245471,0.00006136998,0.00040337432,0.0015723372,0.9887207,0.000014960882],"about_ca_topic_score_codex":0.0011388052,"about_ca_topic_score_gemma":0.0021918067,"teacher_disagreement_score":0.0060885176,"about_ca_system_score_codex":0.00052352285,"about_ca_system_score_gemma":0.0011567753,"threshold_uncertainty_score":0.020368159},"labels":[],"label_agreement":null},{"id":"W2027200715","doi":"10.2147/vhrm.s54714","title":"Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty","year":2014,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"Bayer HealthCare; Janssen Scientific Affairs","keywords":"Medicine; Rivaroxaban; Number needed to harm; Pulmonary embolism; Deep vein; Number needed to treat; Adverse effect; Placebo; Anesthesia; Surgery; Thrombosis; Relative risk; Internal medicine; Warfarin; Confidence interval; Atrial fibrillation","score_opus":0.019149418282129134,"score_gpt":0.30791315503027317,"score_spread":0.28876373674814404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027200715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83923644,0.10619251,0.020886185,0.0025907839,0.002117539,0.009840769,0.004580091,0.00033968818,0.014215983],"genre_scores_gemma":[0.98019606,0.0068939687,0.0068986644,0.00056827744,0.0006796531,0.0022450467,0.00065056473,0.000033208635,0.0018344632],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9847661,0.010848372,0.0012746723,0.00082576246,0.0020317435,0.00025335458],"domain_scores_gemma":[0.9812538,0.012036033,0.0047689676,0.0005763799,0.00081884017,0.0005460361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018286444,0.0015386693,0.0031666155,0.001567326,0.00023727214,0.0016485826,0.0008450014,0.0011933214,0.0049506603],"category_scores_gemma":[0.031387568,0.000533102,0.0074667935,0.00062808354,0.00079913915,0.0011445087,0.0010771069,0.0021899878,0.0004673915],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84028625,0.0015337857,0.009992648,0.010784468,0.037638668,0.00010744122,0.00015007745,0.0037940675,0.0030026615,0.0010557345,0.0012788692,0.09037532],"study_design_scores_gemma":[0.40195873,0.29723042,0.08903091,0.0042764354,0.13391829,0.00071331515,0.0003409855,0.026435053,0.018096842,0.0101633975,0.017518952,0.00031662782],"about_ca_topic_score_codex":0.0002757717,"about_ca_topic_score_gemma":0.0004469316,"teacher_disagreement_score":0.018286444,"about_ca_system_score_codex":0.0009028083,"about_ca_system_score_gemma":0.0009697385,"threshold_uncertainty_score":0.09670913},"labels":[],"label_agreement":null},{"id":"W2041269545","doi":"10.2147/vhrm.s29144","title":"Endoglin: a critical mediator of cardiovascular health","year":2013,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Vascular Anomalies and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Heart and Stroke Foundation; University of Toronto","funders":"National Heart, Lung, and Blood Institute","keywords":"Endoglin; Medicine; Disease; Mediator; Cardiac fibrosis; SUPERFAMILY; Transforming growth factor; Transforming growth factor beta; Fibrosis; Bioinformatics; Receptor; Internal medicine; Genetics; Biology","score_opus":0.03946597628389597,"score_gpt":0.34924582665145665,"score_spread":0.30977985036756067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041269545","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018797083,0.9983381,0.00012571644,0.00022161138,0.00012155224,0.0000032471692,0.000023319473,0.000007965651,0.0009705788],"genre_scores_gemma":[0.00090483326,0.9980642,0.00015331469,0.00014321457,0.00010808031,0.000004225108,0.00003976925,0.0000011249533,0.0005811211],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989116,0.0000137577545,0.000017168779,0.000015703474,0.000050157418,0.000012006411],"domain_scores_gemma":[0.9999056,0.000034772664,0.000018111241,0.000002602643,0.000025701991,0.000013216655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024389375,0.0006135073,0.00082904985,0.0013943147,0.00020709947,0.00075927866,0.0003660432,0.0006906379,0.002730702],"category_scores_gemma":[0.00033534438,0.0001439474,0.00027842144,0.0013211747,0.00024658476,0.0006639573,0.0005279575,0.0010124197,0.0015627086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006262626,0.00004546227,0.00026051112,0.010490317,0.00009609413,0.00024371443,0.00005128164,0.00014408183,0.003867687,0.002411287,0.025110742,0.9572162],"study_design_scores_gemma":[0.000016042983,0.000054263863,0.0012127255,0.0020833218,0.00010703183,0.0016916391,0.000058872087,0.000046571833,0.0009946572,0.0013112789,0.9924085,0.000014942997],"about_ca_topic_score_codex":0.000553311,"about_ca_topic_score_gemma":0.0008619689,"teacher_disagreement_score":0.002730702,"about_ca_system_score_codex":0.00034840757,"about_ca_system_score_gemma":0.00081205973,"threshold_uncertainty_score":0.009135067},"labels":[],"label_agreement":null},{"id":"W2042361694","doi":"10.2147/vhrm.s57116","title":"Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation","year":2014,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Neurological diseases and metabolism","field":"Neuroscience","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"KGK Synergize (Canada)","funders":"","keywords":"Medicine; Placebo; Internal medicine; Homocysteine; Statin; Population; Cholesterol; Gastroenterology; Placebo-controlled study; Endocrinology","score_opus":0.020686356380752183,"score_gpt":0.26737301043679246,"score_spread":0.2466866540560403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042361694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973701,0.0012435355,0.00027366914,0.00013541237,0.00008091272,0.0004976079,0.00011018631,0.00003701428,0.00025138236],"genre_scores_gemma":[0.9950237,0.0013659515,0.0010149955,0.00029219833,0.00017074411,0.00069451943,0.00022237757,0.000011651074,0.0012038775],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99919254,0.0003855245,0.00008977465,0.00013549843,0.00009328991,0.00010336646],"domain_scores_gemma":[0.99927944,0.00017396206,0.00017109884,0.0000834208,0.00007745233,0.00021468155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015158433,0.0008483572,0.0022654394,0.00048028256,0.0004517589,0.0006148876,0.00083584135,0.0017848806,0.0028258867],"category_scores_gemma":[0.0012750553,0.0007204957,0.0008991088,0.0003934261,0.0010101661,0.0006934138,0.0003221093,0.0013981529,0.0003837788],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88153464,0.03385798,0.0011544023,0.0009277019,0.0007265966,0.0000740724,0.00013879267,0.00009750116,0.055651065,0.000044446893,0.0002957817,0.025496924],"study_design_scores_gemma":[0.5596396,0.42337742,0.009548197,0.000050377566,0.00081162807,0.00011385841,0.00008041304,0.00040354222,0.005293439,0.00006223796,0.00059117517,0.00002817766],"about_ca_topic_score_codex":0.0006996801,"about_ca_topic_score_gemma":0.0018913499,"teacher_disagreement_score":0.0028258867,"about_ca_system_score_codex":0.0003555581,"about_ca_system_score_gemma":0.00062984205,"threshold_uncertainty_score":0.009453535},"labels":[],"label_agreement":null},{"id":"W2048382309","doi":"10.2147/vhrm.s50464","title":"Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study","year":2013,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Bioavailability; Medicine; Eicosapentaenoic acid; Pharmacokinetics; Dosing; Docosahexaenoic acid; Fatty acid; Omega 3 fatty acid; Pharmacology; Internal medicine; Biochemistry; Chemistry; Polyunsaturated fatty acid","score_opus":0.022459342694400225,"score_gpt":0.28002422180640146,"score_spread":0.2575648791120012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048382309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991357,0.00018770521,0.0001862802,0.000032623877,0.000015650226,0.00005827061,0.00011478634,0.000012636828,0.00025639043],"genre_scores_gemma":[0.99581957,0.0005472981,0.00060296454,0.000104381674,0.00005236571,0.00012858844,0.0005881257,0.000022776027,0.0021338228],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997346,0.00008829931,0.000021562251,0.000051896113,0.00004575075,0.000057832603],"domain_scores_gemma":[0.999652,0.000058517075,0.000097389,0.00005351715,0.000023984483,0.000114667935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007281597,0.00061901804,0.0013356997,0.00024912562,0.00021304147,0.00058156566,0.0003789407,0.00056529645,0.0022646356],"category_scores_gemma":[0.0005930066,0.00033769745,0.000849924,0.0001991328,0.00043687382,0.00049375225,0.00035516865,0.0012133457,0.00047042719],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6776681,0.035450853,0.005903987,0.00029053944,0.00050327287,0.00016032394,0.0001738288,0.0002501235,0.2414865,0.00009875462,0.00042949882,0.037584208],"study_design_scores_gemma":[0.06792032,0.82215166,0.04642125,0.00003267686,0.000984192,0.00035086076,0.00014843378,0.0016795698,0.057186253,0.000087706736,0.00296188,0.000075195894],"about_ca_topic_score_codex":0.00097256055,"about_ca_topic_score_gemma":0.001099064,"teacher_disagreement_score":0.0022646356,"about_ca_system_score_codex":0.00038572756,"about_ca_system_score_gemma":0.0004186071,"threshold_uncertainty_score":0.007575989},"labels":[],"label_agreement":null},{"id":"W2054533416","doi":"10.2147/vhrm.2005.1.4.261","title":"Corticosteroids and endothelial dysfunction","year":2005,"lang":"en","type":"letter","venue":"Vascular Health and Risk Management","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Endothelial dysfunction; Intensive care medicine; Internal medicine","score_opus":0.009324793667004316,"score_gpt":0.24234658374507473,"score_spread":0.23302179007807042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054533416","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.122196145,0.83580583,0.00063268753,0.016357413,0.0015763729,0.000053655614,0.00076558953,0.000057088546,0.022555174],"genre_scores_gemma":[0.7335493,0.24564067,0.00083486224,0.0067197075,0.0027234533,0.000056195982,0.0005469415,0.000015683732,0.009913256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999233,0.0002711778,0.00007641929,0.000100101446,0.00022288722,0.00009640903],"domain_scores_gemma":[0.99822575,0.00057153375,0.00066522,0.00009191928,0.00023101697,0.0002146905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006140399,0.00031142653,0.0003907055,0.0005738474,0.00041566117,0.0012908796,0.00029767337,0.0015599263,0.0056846077],"category_scores_gemma":[0.002299552,0.0001530099,0.00050226034,0.00088929717,0.0002725202,0.000437126,0.00042390273,0.0017134267,0.0006270691],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076607754,0.0014127035,0.28390703,0.0050630914,0.0026834619,0.0065866383,0.00053341547,0.00035872115,0.010071897,0.0082740085,0.049121585,0.62432665],"study_design_scores_gemma":[0.0005257844,0.0024872052,0.8036121,0.0020403056,0.0016197847,0.015776604,0.0004759398,0.00049118337,0.00262142,0.008879396,0.16134349,0.00012673301],"about_ca_topic_score_codex":0.0021981879,"about_ca_topic_score_gemma":0.002286959,"teacher_disagreement_score":0.0056846077,"about_ca_system_score_codex":0.0005796982,"about_ca_system_score_gemma":0.00050265045,"threshold_uncertainty_score":0.019016922},"labels":[],"label_agreement":null},{"id":"W2056362163","doi":"10.2147/vhrm.2006.2.2.125","title":"Valsartan in the treatment of heart attack survivors","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Health Sciences Centre","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Valsartan; Cardiology; Heart failure; Internal medicine; ACE inhibitor; Myocardial infarction; Atrial fibrillation; Angiotensin II; Angiotensin II receptor type 1; Left ventricular hypertrophy; Angiotensin-converting enzyme; Blood pressure","score_opus":0.04892616212015362,"score_gpt":0.3608771020874571,"score_spread":0.3119509399673035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056362163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002588607,0.9990675,0.000025858695,0.00008564419,0.00006220791,0.0000047064796,0.000010022102,0.00000403352,0.00048119764],"genre_scores_gemma":[0.0017287158,0.9976629,0.00008176551,0.00014189142,0.000068168345,0.000006940457,0.000021890466,7.611134e-7,0.00028711415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998598,0.000037553425,0.000027178574,0.000017091883,0.00004836333,0.000010010995],"domain_scores_gemma":[0.9998566,0.00006249928,0.00003874777,0.0000032528992,0.000025767902,0.00001314228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037431536,0.00047396525,0.0012678867,0.0012056523,0.00015865226,0.0004095571,0.0006212578,0.0005622915,0.0025646447],"category_scores_gemma":[0.00050585374,0.0001533318,0.0004112586,0.0012292858,0.0001716365,0.00034174288,0.00029889567,0.0008376517,0.00086408405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030232873,0.00010875574,0.0002695674,0.023822242,0.0002513737,0.00025813616,0.000051726685,0.00020137092,0.0007622868,0.0005437678,0.016174993,0.9572534],"study_design_scores_gemma":[0.000662339,0.00085962715,0.0074800747,0.024773322,0.0014967149,0.00480838,0.00018709766,0.00027424548,0.0012914639,0.002032635,0.9561029,0.000031159576],"about_ca_topic_score_codex":0.00092247804,"about_ca_topic_score_gemma":0.0022802644,"teacher_disagreement_score":0.0025646447,"about_ca_system_score_codex":0.00022309857,"about_ca_system_score_gemma":0.0004357724,"threshold_uncertainty_score":0.008579552},"labels":[],"label_agreement":null},{"id":"W2057146024","doi":"10.2147/vhrm.s61966","title":"Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease","year":2014,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Island Health; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Guideline; Statin; ACE inhibitor; Medical prescription; Vascular disease; Population; Vascular surgery; Internal medicine; Physical therapy; Intensive care medicine; Emergency medicine; Angiotensin-converting enzyme; Blood pressure; Pharmacology; Cardiac surgery","score_opus":0.04049451421858204,"score_gpt":0.3058371728529314,"score_spread":0.26534265863434936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057146024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849415,0.00012832953,0.00006630187,0.00034569725,0.000018909155,0.000087139706,0.00039881293,0.00000294893,0.00045765314],"genre_scores_gemma":[0.99921644,0.000047386176,0.0001523739,0.0001631021,0.000020194262,0.00005577532,0.00025482857,0.0000020209666,0.000087839166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936352,0.0031164957,0.00068869273,0.00067415956,0.00091887364,0.00096665224],"domain_scores_gemma":[0.95879734,0.011864702,0.015293871,0.0013304765,0.0048472197,0.007866305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005850468,0.00030511816,0.0005188079,0.00097588776,0.0014774561,0.0018083414,0.0008677858,0.0008157052,0.0028245114],"category_scores_gemma":[0.031031398,0.00028290445,0.0016287761,0.002211641,0.0009459556,0.0012402305,0.001644517,0.0018060439,0.00021189445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054603495,0.00033457592,0.99649745,0.000020822383,0.00013454605,0.00003403324,0.00029674766,0.000040362473,0.000027066104,0.00002707359,0.00025731797,0.0017840145],"study_design_scores_gemma":[0.00013338555,0.0009397318,0.9972965,0.000026796415,0.000081791004,0.0000394393,0.0009769818,0.00026009118,0.000021552767,0.000025355364,0.0001875517,0.000010705893],"about_ca_topic_score_codex":0.087602384,"about_ca_topic_score_gemma":0.09911763,"teacher_disagreement_score":0.087602384,"about_ca_system_score_codex":0.0053219423,"about_ca_system_score_gemma":0.006466896,"threshold_uncertainty_score":0.17418498},"labels":[],"label_agreement":null},{"id":"W2063979477","doi":"10.2147/vhrm.2006.2.3.285","title":"Metabolic syndrome: the danger signal in atherosclerosis","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research; Sanofi","keywords":"Medicine; Metabolic syndrome; Adipokine; Inflammation; Immune system; Adipose tissue; Pathophysiology; Immunology; Disease; Innate immune system; Bioinformatics; Internal medicine; Endocrinology; Diabetes mellitus; Insulin resistance; Biology","score_opus":0.02467027535985939,"score_gpt":0.29557234694411816,"score_spread":0.2709020715842588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063979477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011720357,0.99765426,0.00014408698,0.0003883937,0.00043157142,0.000004561714,0.000008960759,0.000008155854,0.0012429701],"genre_scores_gemma":[0.0007531156,0.9969614,0.00022693988,0.00025185154,0.00036407486,0.000005882876,0.000024343066,0.0000012004243,0.0014111977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998523,0.000031245378,0.00001944864,0.000018903049,0.00006442873,0.000013562417],"domain_scores_gemma":[0.9998853,0.00002937726,0.000019928117,0.0000040281343,0.00004020702,0.000021129397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031126238,0.0008846296,0.0013984931,0.0014993065,0.00036296793,0.0009309745,0.0006163618,0.0011977918,0.0037598372],"category_scores_gemma":[0.00032507832,0.0001674666,0.0002738561,0.0020852617,0.00035229314,0.0011361955,0.00060571625,0.0015079776,0.0034744663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011154724,0.00007832873,0.0002678731,0.008592492,0.00006626014,0.0005698237,0.00009965796,0.00016720762,0.0025913669,0.0040678037,0.050214674,0.93317294],"study_design_scores_gemma":[0.000022145614,0.00009337996,0.0011907206,0.0026868333,0.000051199728,0.0037757608,0.00010135197,0.000060979273,0.00045435713,0.0025628787,0.9889839,0.00001646157],"about_ca_topic_score_codex":0.00074782484,"about_ca_topic_score_gemma":0.0012111581,"teacher_disagreement_score":0.0037598372,"about_ca_system_score_codex":0.0004480644,"about_ca_system_score_gemma":0.0009507549,"threshold_uncertainty_score":0.012577891},"labels":[],"label_agreement":null},{"id":"W2072285004","doi":"10.2147/vhrm.s6668","title":"Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence","year":2010,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University; GlaxoSmithKline; American Diabetes Association","keywords":"Medicine; Dosing; Regimen; Diabetes mellitus; Blood pressure; Intensive care medicine; Disease; BETA (programming language); Drug class; Internal medicine; Pharmacology; Drug; Endocrinology","score_opus":0.06937492799736371,"score_gpt":0.3418635859320006,"score_spread":0.2724886579346369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072285004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002269615,0.763327,0.054243606,0.15195715,0.006893204,0.0013052141,0.0007919835,0.00050106243,0.018711073],"genre_scores_gemma":[0.03124672,0.61171234,0.27445197,0.06520868,0.0061200317,0.003712314,0.0010779892,0.00036200727,0.0061079124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9760442,0.011031312,0.006562343,0.00088737573,0.0052046743,0.00027004804],"domain_scores_gemma":[0.9760423,0.0132503,0.0028278276,0.0008078049,0.0064397193,0.0006321114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024851974,0.0014856134,0.004625907,0.004272397,0.0010713796,0.004921231,0.0035372085,0.0043876055,0.005458381],"category_scores_gemma":[0.05146286,0.0009990562,0.0026143878,0.0027236613,0.0031916774,0.00677012,0.002764279,0.012150237,0.004762809],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091579044,0.00069736235,0.0021844637,0.01025158,0.00062338065,0.00036296094,0.00064360636,0.0013997697,0.0013780498,0.02510258,0.16503584,0.79140455],"study_design_scores_gemma":[0.001763993,0.0019579679,0.0072042495,0.064587966,0.0012227389,0.0015734102,0.0011751533,0.004335759,0.0014535971,0.09391363,0.82051885,0.0002927133],"about_ca_topic_score_codex":0.0029797165,"about_ca_topic_score_gemma":0.0038551418,"teacher_disagreement_score":0.024851974,"about_ca_system_score_codex":0.003874465,"about_ca_system_score_gemma":0.0071331947,"threshold_uncertainty_score":0.1314314},"labels":[],"label_agreement":null},{"id":"W2072298699","doi":"10.2147/vhrm.2006.2.3.221","title":"Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Medicine; Atrial fibrillation; Disease; C-reactive protein; Heart failure; Cardiology; Internal medicine; Pathophysiology; Inflammation; Myocarditis; Intensive care medicine; Systemic inflammation","score_opus":0.022041387707686252,"score_gpt":0.34479521992897977,"score_spread":0.3227538322212935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072298699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045575045,0.9974777,0.00007898474,0.00087225175,0.0011372137,0.0000035508288,0.000004252765,0.000003498256,0.00037694845],"genre_scores_gemma":[0.00038250268,0.99697196,0.00023725738,0.00060138426,0.0013914395,0.000006661336,0.000010656324,0.0000014069252,0.00039666216],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991708,0.00024400631,0.00015473155,0.000088550485,0.0003022049,0.000039838407],"domain_scores_gemma":[0.99833137,0.0007429506,0.00018567196,0.000043517015,0.00057421235,0.0001223113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021202515,0.001368626,0.0024721657,0.0038244724,0.00044667078,0.0016133216,0.001414657,0.0023779878,0.0025861901],"category_scores_gemma":[0.0027851611,0.00036758743,0.000650393,0.003946807,0.0010681729,0.0024576038,0.0009832189,0.002994779,0.0022198278],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001357416,0.000069495516,0.000257813,0.021965617,0.00014687347,0.0009196248,0.00017828676,0.00024429362,0.0010604571,0.0033444716,0.131679,0.8399983],"study_design_scores_gemma":[0.000037892696,0.000107220054,0.0010808846,0.010540356,0.00013315961,0.0031736684,0.00018211216,0.00009132945,0.00026277872,0.0025059772,0.98185766,0.000026908205],"about_ca_topic_score_codex":0.0011776004,"about_ca_topic_score_gemma":0.0021840327,"teacher_disagreement_score":0.0038244724,"about_ca_system_score_codex":0.0011150494,"about_ca_system_score_gemma":0.0019310198,"threshold_uncertainty_score":0.011213124},"labels":[],"label_agreement":null},{"id":"W2075102176","doi":"10.2147/vhrm.2006.2.4.379","title":"Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Hamilton Health Sciences; Sanofi; McMaster University; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Cardiology; Percutaneous coronary intervention; Internal medicine; Myocardial infarction; Aspirin; Thrombus; Ticlopidine","score_opus":0.06356072955798536,"score_gpt":0.3606762692281438,"score_spread":0.2971155396701584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075102176","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008291628,0.9959459,0.00011449006,0.0010039001,0.0012329567,0.000014528042,0.000026331309,0.000010763149,0.0015682806],"genre_scores_gemma":[0.0003547901,0.996469,0.00036407972,0.0008905716,0.0009145311,0.000013136859,0.00006153638,0.0000020995394,0.00093014736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994504,0.00012292778,0.000102744016,0.000043155007,0.0002536283,0.000027218895],"domain_scores_gemma":[0.9989685,0.00036737724,0.00016077505,0.000021993319,0.00038845369,0.00009296626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010459498,0.0012365845,0.0022255257,0.0034082797,0.00036781057,0.0012002707,0.0014316284,0.002261496,0.0052521056],"category_scores_gemma":[0.0018841882,0.0003747965,0.0007769024,0.0041771214,0.00043810616,0.0018009724,0.00073187053,0.0025607953,0.004526618],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095649084,0.000118196825,0.00015281081,0.01733902,0.00012229482,0.00038602683,0.00007395822,0.00018673982,0.0007146785,0.0011187658,0.194224,0.78546786],"study_design_scores_gemma":[0.00004876802,0.00008727674,0.0009407012,0.0054397313,0.00017533037,0.0017860525,0.000042330605,0.00007207548,0.00009812283,0.00057077745,0.99072355,0.000015326628],"about_ca_topic_score_codex":0.0020008828,"about_ca_topic_score_gemma":0.005076869,"teacher_disagreement_score":0.0052521056,"about_ca_system_score_codex":0.0006478118,"about_ca_system_score_gemma":0.0016960711,"threshold_uncertainty_score":0.017570019},"labels":[],"label_agreement":null},{"id":"W2078035712","doi":"10.2147/vhrm.s55246","title":"Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk","year":2014,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Janssen Research and Development; Bayer HealthCare","keywords":"Rivaroxaban; Medicine; Atrial fibrillation; Warfarin; Intensive care medicine; Stroke (engine); Dosing; Dabigatran; Anticoagulant; Apixaban; Edoxaban; Clinical trial; Internal medicine","score_opus":0.05452617617708271,"score_gpt":0.3750624257402439,"score_spread":0.3205362495631612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078035712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063807133,0.89703006,0.0069349697,0.07993376,0.0036226786,0.00060252374,0.00065248954,0.00019485471,0.010390537],"genre_scores_gemma":[0.005370753,0.89861965,0.05786855,0.031742387,0.0013700743,0.0008222759,0.00073279947,0.000044130622,0.003429381],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931886,0.0028583647,0.0020144947,0.00030610742,0.0015131546,0.00011925969],"domain_scores_gemma":[0.9915765,0.0048954543,0.0012085258,0.00020627829,0.0018970119,0.00021625758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008568783,0.0015364636,0.0025887042,0.003423057,0.00067242654,0.0019883127,0.0029576386,0.005935977,0.006881545],"category_scores_gemma":[0.022579554,0.00092390034,0.002119123,0.0028672037,0.0013978693,0.003938083,0.0013061608,0.005441355,0.0036632055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014082152,0.00014150608,0.0005357181,0.05676531,0.00048199252,0.00049363065,0.000657687,0.0005420728,0.0007712318,0.009784987,0.24495961,0.68472534],"study_design_scores_gemma":[0.0003068398,0.00011191012,0.0016268741,0.10198402,0.0008267336,0.0013395172,0.0005627546,0.00038652666,0.0002791172,0.020688653,0.8717973,0.00008984542],"about_ca_topic_score_codex":0.0034056394,"about_ca_topic_score_gemma":0.008364495,"teacher_disagreement_score":0.008568783,"about_ca_system_score_codex":0.0014014002,"about_ca_system_score_gemma":0.006322576,"threshold_uncertainty_score":0.045316577},"labels":[],"label_agreement":null},{"id":"W2089332819","doi":"10.2147/vhrm.2006.2.4.371","title":"Fondaparinux in the management of patients with ST-elevation acute myocardial infarction","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Fondaparinux; Medicine; Myocardial infarction; Internal medicine; Percutaneous coronary intervention; Heparin; ST elevation; Cardiology; Placebo; Thrombosis; Venous thromboembolism","score_opus":0.0219480472324214,"score_gpt":0.3284135734351888,"score_spread":0.3064655262027674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089332819","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5921711,0.3931425,0.00065692974,0.006549121,0.0006545518,0.00013574591,0.00016849765,0.00006744429,0.006454182],"genre_scores_gemma":[0.9263038,0.068823025,0.0012471937,0.0013861288,0.0009842484,0.0000911467,0.00024193693,0.0000040574805,0.0009184975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968433,0.00016047177,0.00003960075,0.000020815058,0.00007463562,0.0000202437],"domain_scores_gemma":[0.9997149,0.00009455554,0.00009986065,0.0000067287215,0.000021366708,0.000062559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058679335,0.00020043405,0.00053177314,0.00026325387,0.00011842842,0.0002830035,0.00017845054,0.00034449747,0.0004974842],"category_scores_gemma":[0.0014881266,0.00006223088,0.000281732,0.00033499132,0.00010678355,0.00019528216,0.00013520184,0.0006373084,0.00010444374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02046617,0.0017310668,0.04155912,0.0020365969,0.0010367208,0.0008817296,0.00023541712,0.0011778413,0.003726268,0.00068057695,0.009399584,0.917069],"study_design_scores_gemma":[0.03536763,0.06146984,0.76957124,0.0023403584,0.003485282,0.009148244,0.0005349182,0.0059054433,0.00402517,0.0037176516,0.10429783,0.00013647538],"about_ca_topic_score_codex":0.0005022419,"about_ca_topic_score_gemma":0.0008666855,"teacher_disagreement_score":0.00058679335,"about_ca_system_score_codex":0.000221466,"about_ca_system_score_gemma":0.000335787,"threshold_uncertainty_score":0.0031033158},"labels":[],"label_agreement":null},{"id":"W2090687235","doi":"10.2147/vhrm.s30064","title":"Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery","year":2012,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Rivaroxaban; Venous thromboembolism; Venous thrombosis; Surgery; Hip surgery; Thrombosis; Arthroplasty; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.02666006372937954,"score_gpt":0.2790618897759476,"score_spread":0.252401826046568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090687235","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016533671,0.00515081,0.021480748,0.0071585607,0.006896099,0.92250586,0.004951407,0.00026167498,0.015061208],"genre_scores_gemma":[0.033247545,0.0021286104,0.03596285,0.007046355,0.0021343152,0.9128603,0.0014047294,0.000057392674,0.005157943],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9694508,0.01787343,0.0026325635,0.003346867,0.005208024,0.0014884343],"domain_scores_gemma":[0.97988987,0.0054655895,0.0020858075,0.0027256631,0.005135729,0.0046973587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.055950873,0.0033210183,0.0032608623,0.0018608953,0.0030975626,0.002705475,0.0033341488,0.005301515,0.024965828],"category_scores_gemma":[0.039201885,0.0021501991,0.0020114013,0.0015973343,0.0035927303,0.0024253193,0.002020542,0.005960569,0.010537391],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4357407,0.044599343,0.02827754,0.024181867,0.0022431128,0.0025613147,0.0039806147,0.002390783,0.014422704,0.089790985,0.099169075,0.25264207],"study_design_scores_gemma":[0.23331597,0.10802732,0.028381767,0.008833925,0.0023478891,0.0013457211,0.0010250249,0.00448643,0.004806861,0.03200072,0.57496864,0.00045975705],"about_ca_topic_score_codex":0.0008234567,"about_ca_topic_score_gemma":0.0017369946,"teacher_disagreement_score":0.055950873,"about_ca_system_score_codex":0.0018806116,"about_ca_system_score_gemma":0.014627845,"threshold_uncertainty_score":0.2959},"labels":[],"label_agreement":null},{"id":"W2092278852","doi":"10.2147/vhrm.1.1.5.58931","title":"Coxibs: can this class of drugs survive?","year":2005,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Class (philosophy); Artificial intelligence","score_opus":0.005923473833793288,"score_gpt":0.24513648772092075,"score_spread":0.23921301388712746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092278852","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017653619,0.34484145,0.0010649454,0.6148119,0.019831832,0.000028256172,0.00030421533,0.00015202088,0.01720005],"genre_scores_gemma":[0.028150985,0.52698076,0.0019045575,0.3489903,0.04977937,0.00008826224,0.00060014206,0.00013976022,0.043365877],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980159,0.000491093,0.00014350553,0.00025066672,0.0007541976,0.00034470033],"domain_scores_gemma":[0.99386543,0.0017119774,0.00072709715,0.00035675926,0.0015207935,0.0018179206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058116005,0.0007891234,0.0017340751,0.00067879213,0.0014546065,0.00635052,0.0012673627,0.0073220744,0.025683245],"category_scores_gemma":[0.0108272545,0.0002849091,0.00082349277,0.00083966396,0.003104386,0.011007283,0.0025342035,0.011372609,0.012880803],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004313129,0.00010030414,0.0008734957,0.0012480797,0.00007111536,0.0004271643,0.00027204832,0.00011945835,0.0007157215,0.031804457,0.6420495,0.32188737],"study_design_scores_gemma":[0.00009854676,0.00021715394,0.0005404402,0.0012778569,0.00003575805,0.00052715273,0.00031728754,0.00009894671,0.00018657994,0.025734464,0.9709301,0.000035790807],"about_ca_topic_score_codex":0.0011297663,"about_ca_topic_score_gemma":0.0033535473,"teacher_disagreement_score":0.025683245,"about_ca_system_score_codex":0.0014622319,"about_ca_system_score_gemma":0.0029875676,"threshold_uncertainty_score":0.08591902},"labels":[],"label_agreement":null},{"id":"W2095539779","doi":"10.2147/vhrm.2006.2.2.171","title":"Vascular risks and management of obesity in children and adolescents","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Obesity, Physical Activity, Diet","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Obesity; Overweight; Dyslipidemia; Pharmacotherapy; Pediatrics; Metabolic syndrome; Childhood obesity; Disease; Diabetes mellitus; Population; Environmental health; Internal medicine; Endocrinology","score_opus":0.022400975595227347,"score_gpt":0.31225784491910025,"score_spread":0.2898568693238729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095539779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031135688,0.9989047,0.00005286657,0.00015558826,0.00007157998,0.0000045591937,0.0000077879495,0.000003031091,0.00048855337],"genre_scores_gemma":[0.0016137209,0.99769956,0.00023302814,0.00008978553,0.000087193665,0.000007913113,0.000013694923,6.340112e-7,0.0002544034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998073,0.000054025328,0.000031729214,0.000022679782,0.00006729333,0.000016922875],"domain_scores_gemma":[0.9998036,0.000090252375,0.0000498976,0.00000477799,0.000034513352,0.00001691873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004428293,0.0006583281,0.0013854912,0.0014908457,0.00023982562,0.00065127906,0.0005762329,0.0007928341,0.0020001517],"category_scores_gemma":[0.00072236604,0.0001983795,0.00046287486,0.0012877138,0.00028569927,0.0005204786,0.00035017577,0.0011406281,0.0006655006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008622651,0.00013905978,0.0007853425,0.019342043,0.0001673974,0.0004163346,0.0000969761,0.00020640307,0.0005614809,0.00095289975,0.01176636,0.9654795],"study_design_scores_gemma":[0.00013891855,0.00047431618,0.019215325,0.037793342,0.000854437,0.010253504,0.00044051788,0.00024226762,0.0011379394,0.0031696092,0.9262387,0.000041072195],"about_ca_topic_score_codex":0.0018298172,"about_ca_topic_score_gemma":0.0030989794,"teacher_disagreement_score":0.0020001517,"about_ca_system_score_codex":0.0003483483,"about_ca_system_score_gemma":0.00083739235,"threshold_uncertainty_score":0.006691158},"labels":[],"label_agreement":null},{"id":"W2119535512","doi":"10.2147/vhrm.s55298","title":"Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey","year":2014,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Saint-Sacrement; Lawson Health Research Institute; Western University","funders":"","keywords":"Medicine; Framingham Risk Score; Blood pressure; Internal medicine; Cohort; Regimen; Cardiology; Framingham Heart Study; Cohort study; Physical therapy; Disease","score_opus":0.024559338107928482,"score_gpt":0.30136413815682805,"score_spread":0.27680480004889957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119535512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238455,0.0003769223,0.00023264112,0.00027373814,0.000010141674,0.00018543539,0.004616898,0.000014461963,0.0019050835],"genre_scores_gemma":[0.99621564,0.00030396925,0.00033334416,0.00013041178,0.000013499665,0.000076777076,0.0024280222,0.00000545685,0.0004928528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99413717,0.0012203855,0.00034274298,0.000604239,0.0030664108,0.00062897574],"domain_scores_gemma":[0.9907238,0.001309338,0.0023074422,0.0007104682,0.0041597905,0.0007891701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068288688,0.00040772313,0.00052853656,0.0010808829,0.0011055677,0.0007535898,0.00086288847,0.00036980462,0.001189553],"category_scores_gemma":[0.01369168,0.0003185527,0.0010608925,0.0023811993,0.0005980497,0.00033472123,0.00083137886,0.0004800295,0.00020647266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033868352,0.00009374818,0.9925476,0.000031977623,0.00014376262,0.00002398984,0.00039555843,0.00011510589,0.00006784741,0.000052975247,0.00087335013,0.0053154095],"study_design_scores_gemma":[0.00003736382,0.000082808896,0.99915195,0.000004593692,0.000035625988,0.000015091165,0.00009735671,0.00021554547,0.000032738855,0.0000072582775,0.00031118246,0.000008391356],"about_ca_topic_score_codex":0.93130577,"about_ca_topic_score_gemma":0.9120783,"teacher_disagreement_score":0.068694234,"about_ca_system_score_codex":0.008666903,"about_ca_system_score_gemma":0.010369972,"threshold_uncertainty_score":0.13819754},"labels":[],"label_agreement":null},{"id":"W2129219826","doi":"10.2147/vhrm.s30089","title":"Smoking status and sex as indicators of differences in 2582 obese patients presenting for weight management","year":2012,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Weight management; Obesity; Body mass index; Demography; Environmental health; Gerontology; Overweight; Internal medicine","score_opus":0.015337176029461825,"score_gpt":0.2900881682569985,"score_spread":0.2747509922275367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129219826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99952626,0.00006712471,0.000012953586,0.000018886201,0.0000036095064,0.000006755315,0.00018718143,9.893764e-7,0.00017625486],"genre_scores_gemma":[0.99945897,0.00004030518,0.000031077456,0.00001956695,0.0000055381292,0.00000997764,0.00032309387,0.0000011634074,0.000110286266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997105,0.000048995127,0.00004429567,0.00005730023,0.00007316744,0.000065707194],"domain_scores_gemma":[0.999035,0.00016317282,0.000421615,0.000041549247,0.000081068196,0.00025764303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041917534,0.00022196575,0.00033210966,0.00070674595,0.00045042805,0.00054547394,0.00030922683,0.00045629742,0.0019284721],"category_scores_gemma":[0.0015668016,0.00025813215,0.00030623082,0.0008299514,0.00024355241,0.00032608522,0.00043419193,0.0006063091,0.00033702652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006359011,0.000020900752,0.9994728,0.0000019151817,0.000007836901,0.000064047854,0.000039835933,0.0000055990495,0.00005610154,0.0000029059208,0.000024190096,0.00024038169],"study_design_scores_gemma":[0.000005101758,0.00007630945,0.99941766,0.0000021169674,0.000007342595,0.0001996923,0.0001586275,0.000057907415,0.000013665373,0.0000047161457,0.00005499798,0.0000019026696],"about_ca_topic_score_codex":0.007901111,"about_ca_topic_score_gemma":0.012456844,"teacher_disagreement_score":0.007901111,"about_ca_system_score_codex":0.0004092449,"about_ca_system_score_gemma":0.00032309195,"threshold_uncertainty_score":0.015710235},"labels":[],"label_agreement":null},{"id":"W2148343657","doi":"10.2147/vhrm.s6611","title":"Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia","year":2010,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Amiodarone; Medicine; Ventricular tachycardia; Ventricular fibrillation; Cardiology; Internal medicine; Refractory (planetary science); Implantable cardioverter-defibrillator; Atrial fibrillation; Anesthesia","score_opus":0.015913797147777728,"score_gpt":0.31253658034412424,"score_spread":0.2966227831963465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148343657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000100234036,0.9986376,0.0000622891,0.00012898285,0.00015599157,0.0000047875383,0.000009467057,0.000004416898,0.0008961342],"genre_scores_gemma":[0.00069982937,0.99831843,0.00012766772,0.00010277985,0.00015053095,0.000004337344,0.000020040017,9.41334e-7,0.0005754649],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998092,0.000031381456,0.000037251193,0.000027942247,0.00007781265,0.000016408503],"domain_scores_gemma":[0.99972135,0.00011111101,0.00005552402,0.0000075819225,0.00007896854,0.00002534696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040463073,0.00076245226,0.0011015009,0.002844677,0.00023520376,0.0005593752,0.00057264016,0.00065596733,0.0046884664],"category_scores_gemma":[0.0006712084,0.00013600806,0.00040073597,0.0026754641,0.00028210506,0.00087791146,0.00041158198,0.0009996536,0.0024800391],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058826226,0.00006154696,0.00027314335,0.012323919,0.00008279949,0.00026544018,0.000041713763,0.00016024028,0.0011784943,0.0011242527,0.02382037,0.96060926],"study_design_scores_gemma":[0.00004859112,0.00012688081,0.003310694,0.0068147425,0.00020747926,0.006019044,0.00008617118,0.00011801895,0.0005909274,0.0014305362,0.98122805,0.00001890687],"about_ca_topic_score_codex":0.00094287284,"about_ca_topic_score_gemma":0.0020817511,"teacher_disagreement_score":0.0046884664,"about_ca_system_score_codex":0.0003854252,"about_ca_system_score_gemma":0.00078522664,"threshold_uncertainty_score":0.015684485},"labels":[],"label_agreement":null},{"id":"W2407975306","doi":"10.2147/vhrm.s100293","title":"The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study","year":2016,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Rivaroxaban; Orthopedic surgery; Anesthesia; Perioperative; Incidence (geometry); Concomitant; Antithrombotic; Surgery; Warfarin; Internal medicine; Atrial fibrillation","score_opus":0.10934566256060278,"score_gpt":0.40241725752263047,"score_spread":0.29307159496202767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407975306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980849,0.00093245524,0.00012983456,0.000035381345,0.00001742153,0.000022545477,0.00057367294,0.0000037604543,0.00020014733],"genre_scores_gemma":[0.99860567,0.000171581,0.00006785432,0.0000308914,0.000027970906,0.00003211116,0.00097201136,0.000005525486,0.000086397704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973978,0.00087908073,0.00049869216,0.0005604375,0.00037313858,0.00029098277],"domain_scores_gemma":[0.9965959,0.001088502,0.0012429411,0.00053944346,0.0001534275,0.00037987976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029009143,0.0007773238,0.0017681622,0.0010620437,0.00029770914,0.00087162724,0.0006522531,0.00062470394,0.0011497069],"category_scores_gemma":[0.0036565443,0.0004075972,0.005101735,0.0011954933,0.0002963674,0.00054173527,0.0006580618,0.0007562761,0.00012991903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014822936,0.00013615028,0.97123677,0.00010366769,0.009014883,0.00019469102,0.000083325795,0.00033563597,0.00085461314,0.00003438779,0.0002864954,0.0028965338],"study_design_scores_gemma":[0.00078796584,0.0016244545,0.99196154,0.000024734294,0.0035097322,0.0002918861,0.00020468942,0.0009553821,0.00026319688,0.0000773183,0.0002795551,0.000019503728],"about_ca_topic_score_codex":0.0018428355,"about_ca_topic_score_gemma":0.0022539191,"teacher_disagreement_score":0.0029009143,"about_ca_system_score_codex":0.0003298746,"about_ca_system_score_gemma":0.0004964853,"threshold_uncertainty_score":0.015341699},"labels":[],"label_agreement":null},{"id":"W2581401145","doi":"10.2147/vhrm.s123631","title":"Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006–2012","year":2017,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Amgen; Amgen Foundation","keywords":"Medicine; Confidence interval; Thrombocytopenic purpura; Thrombotic thrombocytopenic purpura; Population; Pediatrics; Healthcare Cost and Utilization Project; Emergency medicine; Internal medicine; Demography; Health care; Environmental health","score_opus":0.011442180233140059,"score_gpt":0.28256826643944055,"score_spread":0.2711260862063005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581401145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998024,0.00056769693,0.00004980275,0.00012010415,0.0000098782675,0.000006263406,0.0009411435,0.0000033763158,0.00027783334],"genre_scores_gemma":[0.9983571,0.00023075801,0.00008002691,0.000062347965,0.000018708046,0.00000943627,0.0011541583,0.0000010219746,0.000086459935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950624,0.000114310686,0.000112847876,0.000055752193,0.00013016624,0.00008070775],"domain_scores_gemma":[0.99828416,0.00013384645,0.0011637218,0.00004409122,0.00017294096,0.00020117733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044771426,0.00030447886,0.00027079473,0.00096165756,0.00027702627,0.00054520933,0.0003609718,0.00036638396,0.0009049161],"category_scores_gemma":[0.0023347682,0.00022208344,0.00055908336,0.0011720391,0.00019480032,0.00056245545,0.00049600616,0.00063702057,0.00013802265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019045921,0.000017798911,0.99930084,0.0000073409037,0.000040209627,0.000022347927,0.000012703785,0.000025795465,0.000013024384,0.0000038229773,0.000109261906,0.00042776155],"study_design_scores_gemma":[0.0000017071247,0.000021590526,0.99955446,0.000007070291,0.000016375498,0.00010704064,0.00006262768,0.00014063976,0.000012675057,0.0000050854583,0.000069209374,0.0000015087752],"about_ca_topic_score_codex":0.013162793,"about_ca_topic_score_gemma":0.02123063,"teacher_disagreement_score":0.013162793,"about_ca_system_score_codex":0.0008786957,"about_ca_system_score_gemma":0.0005647821,"threshold_uncertainty_score":0.02617234},"labels":[],"label_agreement":null},{"id":"W2589727170","doi":"10.2147/vhrm.s121086","title":"Prevalence of mild cognitive impairment in employable patients after acute coronary event in cardiac rehabilitation","year":2017,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universität Potsdam; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Montreal Cognitive Assessment; Rehabilitation; Internal medicine; Coronary artery disease; Observational study; Prospective cohort study; Cognitive impairment; Cognition; Physical therapy; Cardiology; Disease","score_opus":0.007507652049323215,"score_gpt":0.30594291365464243,"score_spread":0.29843526160531925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589727170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99962544,0.00009767493,0.00001940949,0.000023821407,0.0000026375596,0.000003876803,0.00008018515,0.000001260877,0.00014561783],"genre_scores_gemma":[0.999828,0.000031280753,0.000018762645,0.00000924057,0.0000055036903,0.0000025521538,0.00007377064,2.3425318e-7,0.000030708834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996455,0.00007506773,0.000050752446,0.000053985066,0.000093036884,0.000081672355],"domain_scores_gemma":[0.9986313,0.00015901717,0.0007699992,0.000047890815,0.00008254094,0.00030930084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004818694,0.00019740756,0.0002765687,0.00092460884,0.00037082293,0.00053443556,0.00034324045,0.0003669385,0.0016061311],"category_scores_gemma":[0.0020787239,0.00014565923,0.00029110158,0.0007480982,0.00025181143,0.0002973265,0.00040583193,0.0005055517,0.00017339627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035039902,0.00003332688,0.99936193,0.0000045753345,0.000010230135,0.00003417722,0.000029020413,0.00000804953,0.00004355396,0.0000034237914,0.000022102382,0.00041444637],"study_design_scores_gemma":[0.0000016079877,0.00004533155,0.9997002,0.0000022798777,0.000003872444,0.000110746754,0.00006824159,0.00003425906,0.000008440476,0.000005969307,0.000017979633,0.0000010227446],"about_ca_topic_score_codex":0.004102872,"about_ca_topic_score_gemma":0.005478534,"teacher_disagreement_score":0.004102872,"about_ca_system_score_codex":0.00025314334,"about_ca_system_score_gemma":0.00039055359,"threshold_uncertainty_score":0.008158028},"labels":[],"label_agreement":null},{"id":"W2626741611","doi":"10.2147/vhrm.s138800","title":"Worksite-based cardiovascular risk screening and management: a feasibility study","year":2017,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary; Alberta Health; Libin Cardiovascular Institute of Alberta; Women and Children’s Health Research Institute; University of Alberta","funders":"","keywords":"Medicine; Framingham Risk Score; Dyslipidemia; Risk factor; Blood pressure; Diabetes mellitus; Internal medicine; Physical therapy; Emergency medicine; Disease; Endocrinology","score_opus":0.037189137697289106,"score_gpt":0.3622636777385877,"score_spread":0.3250745400412986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626741611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953284,0.000033239317,0.00030104216,0.00011192313,0.000009793081,0.0027993836,0.000194199,0.000016888956,0.0012050056],"genre_scores_gemma":[0.9924204,0.00014827913,0.0024556078,0.00029663648,0.00006069054,0.0031372183,0.00058776606,0.000007775341,0.0008855997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960801,0.001904892,0.000109044035,0.00029419127,0.00072532456,0.0008865087],"domain_scores_gemma":[0.99386567,0.0010825518,0.0006510595,0.00042581954,0.001302706,0.0026722297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056862333,0.0010712139,0.00043960215,0.0011004788,0.002173222,0.0008649382,0.001854781,0.000991563,0.0023968061],"category_scores_gemma":[0.005422418,0.00068896747,0.000603236,0.00078329764,0.0011404429,0.0007649686,0.0013732447,0.0009854626,0.0008796309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012135974,0.23501348,0.66732466,0.00040670135,0.00016803373,0.0016795779,0.008541973,0.00054302247,0.0042949673,0.00022849928,0.002670575,0.06699256],"study_design_scores_gemma":[0.005535778,0.09192952,0.89123,0.00007145958,0.00013822067,0.00038202165,0.0067238794,0.0013960365,0.00045702714,0.00009342842,0.001965027,0.00007750482],"about_ca_topic_score_codex":0.09894419,"about_ca_topic_score_gemma":0.13559966,"teacher_disagreement_score":0.09894419,"about_ca_system_score_codex":0.0038233537,"about_ca_system_score_gemma":0.010639568,"threshold_uncertainty_score":0.19673651},"labels":[],"label_agreement":null},{"id":"W2744179443","doi":"10.2147/vhrm.s108874","title":"Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance","year":2017,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"Princess Margaret Hospital Foundation","keywords":"Medicine; Myeloid leukemia; Tyrosine kinase; Tyrosine-kinase inhibitor; Immunology; Internal medicine; Cancer; Receptor","score_opus":0.02911039164264766,"score_gpt":0.30605158630237966,"score_spread":0.276941194659732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744179443","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010630038,0.99937254,0.00003875307,0.00015733195,0.000051055555,0.0000038451835,0.000012532218,0.0000014127331,0.00025631432],"genre_scores_gemma":[0.0010331684,0.9986186,0.000084347346,0.000097110336,0.000070831426,0.0000059966947,0.000013933468,3.6228522e-7,0.00007570025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995578,0.00013071297,0.000109687,0.000048927413,0.00013324365,0.000019621546],"domain_scores_gemma":[0.9987459,0.00083105837,0.00020675338,0.00001698168,0.00017426925,0.000024848088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010077697,0.00056634296,0.0012499737,0.0018583304,0.00021801911,0.0008157817,0.00051314634,0.00083749404,0.002736394],"category_scores_gemma":[0.0021253757,0.00017021938,0.0009425567,0.0016059636,0.00024914867,0.0007170472,0.0004462488,0.0009215864,0.00037464293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001191061,0.000056523917,0.00041081986,0.090930946,0.00055131805,0.000092695904,0.000077168464,0.00031620427,0.00056188065,0.0024484198,0.010278542,0.8941564],"study_design_scores_gemma":[0.00015306719,0.00049899524,0.0068831374,0.14128947,0.003926592,0.0028718687,0.00032485602,0.0004456219,0.0009772547,0.0050575724,0.837505,0.00006655872],"about_ca_topic_score_codex":0.0010058115,"about_ca_topic_score_gemma":0.0019740514,"teacher_disagreement_score":0.002736394,"about_ca_system_score_codex":0.00043394638,"about_ca_system_score_gemma":0.0013672562,"threshold_uncertainty_score":0.009154141},"labels":[],"label_agreement":null},{"id":"W2799355091","doi":"10.2147/vhrm.s150474","title":"Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada","year":2018,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Dabigatran; Pulmonary embolism; Arthroplasty; Incidence (geometry); Knee replacement; Venous thrombosis; Hip replacement; Apixaban; Anticoagulant; Surgery; Anesthesia; Fondaparinux; Thrombosis; Venous thromboembolism; Rivaroxaban; Warfarin; Internal medicine; Atrial fibrillation","score_opus":0.009369681575976825,"score_gpt":0.25063240969650424,"score_spread":0.24126272812052743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799355091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97882366,0.00068364793,0.00014143303,0.00013524224,0.00001151691,0.00007957673,0.018641578,0.000024581783,0.0014586847],"genre_scores_gemma":[0.98982084,0.00053732307,0.00014377023,0.00008835853,0.000012173904,0.000031238364,0.008840253,0.000007622566,0.00051844097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998953,0.00007167299,0.000111230365,0.00019293882,0.00041122126,0.0002600079],"domain_scores_gemma":[0.9966905,0.0002054643,0.0011719329,0.00012143835,0.0011210468,0.00068953773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005014237,0.0004645674,0.0005187846,0.0019493205,0.0009633757,0.0008710154,0.0012243389,0.00039181515,0.0018620029],"category_scores_gemma":[0.0019571008,0.00045279902,0.0005097074,0.0042444197,0.0004453519,0.0003310649,0.00062345096,0.000517522,0.0003034637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003650092,0.000014572065,0.9979545,0.00001720118,0.000035613062,0.00007566246,0.000056315792,0.000053598153,0.000072382594,0.000012255624,0.0006496959,0.0010217726],"study_design_scores_gemma":[0.000009394611,0.000022133256,0.9992149,0.000010791147,0.000012729518,0.00008005978,0.00010796238,0.00014151234,0.000030695766,0.000003444594,0.00036182636,0.000004548126],"about_ca_topic_score_codex":0.937534,"about_ca_topic_score_gemma":0.93906885,"teacher_disagreement_score":0.062466025,"about_ca_system_score_codex":0.010184193,"about_ca_system_score_gemma":0.010019538,"threshold_uncertainty_score":0.12566775},"labels":[],"label_agreement":null},{"id":"W2888588674","doi":"10.2147/vhrm.s166111","title":"Prevalence of cardiovascular disease among Bangladeshi adult population: a systematic review and meta-analysis of the studies","year":2018,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Meta-analysis; Epidemiology; Disease; Population; MEDLINE; Demography; Systematic review; Subgroup analysis; Prevalence; Environmental health; Gerontology; Pathology","score_opus":0.055743270723846015,"score_gpt":0.3281741889417558,"score_spread":0.2724309182179098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888588674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003625196,0.9942743,0.00050581846,0.00019761155,0.00011382929,0.00046404006,0.00059604016,0.000017831539,0.00020529094],"genre_scores_gemma":[0.09216355,0.9008607,0.002954556,0.00064019114,0.00020022845,0.0019854412,0.00094483735,0.000024055076,0.00022644586],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9863718,0.005139354,0.005077995,0.0013023919,0.0016918369,0.0004166134],"domain_scores_gemma":[0.9717121,0.019965872,0.0046425494,0.0007546328,0.0026385053,0.0002863572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017302413,0.0030201252,0.020546021,0.010159333,0.0010064006,0.0038319884,0.0025371066,0.0023505925,0.0030787105],"category_scores_gemma":[0.044936556,0.0018998194,0.038128104,0.011516728,0.00076249003,0.0023719324,0.0018806467,0.0019087836,0.00026361205],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078643515,0.000026091515,0.0051288903,0.5994749,0.38193896,0.00020590023,0.00015314449,0.00040451702,0.00017683834,0.00012456176,0.0006489717,0.010930864],"study_design_scores_gemma":[0.0002660251,0.00015176731,0.0046745194,0.063596,0.9288046,0.00017912395,0.00008649684,0.00017390122,0.00012453894,0.0001641813,0.0017498181,0.000029130875],"about_ca_topic_score_codex":0.007937371,"about_ca_topic_score_gemma":0.018524058,"teacher_disagreement_score":0.020546021,"about_ca_system_score_codex":0.003922391,"about_ca_system_score_gemma":0.006698779,"threshold_uncertainty_score":0.09150499},"labels":[],"label_agreement":null},{"id":"W2892141990","doi":"10.2147/vhrm.s170141","title":"Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses","year":2018,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Pfizer (Canada)","funders":"Pfizer","keywords":"Eplerenone; Medicine; Mineralocorticoid receptor; Spironolactone; Aldosterone; Pharmacology; Mineralocorticoid; Antagonist; Internal medicine; Endocrinology; Receptor","score_opus":0.10101055363350885,"score_gpt":0.35716111717230936,"score_spread":0.2561505635388005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892141990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5566911,0.41912603,0.01045266,0.00041156303,0.00071547955,0.0013469508,0.00818282,0.00029909113,0.0027743597],"genre_scores_gemma":[0.97832435,0.015494394,0.0022987134,0.00030120913,0.00022081341,0.0006034709,0.0023778789,0.000047552832,0.00033166297],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9667195,0.02216255,0.0054355725,0.0027633756,0.00242152,0.0004975224],"domain_scores_gemma":[0.9651854,0.020140298,0.009138922,0.0033245853,0.0018116521,0.0003992305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03271831,0.0018207107,0.008783488,0.0028858439,0.00026870923,0.0024048667,0.0008314268,0.0013442521,0.00280414],"category_scores_gemma":[0.031427633,0.00080735894,0.024027932,0.0028151271,0.0006156089,0.0011420645,0.0010213553,0.0009506363,0.00030111457],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08462219,0.000116941825,0.020450361,0.009493193,0.8702149,0.000096651296,0.000057310815,0.0010369334,0.0015796545,0.00007895072,0.0004241664,0.0118286405],"study_design_scores_gemma":[0.02174346,0.009521288,0.06944474,0.0008648731,0.893442,0.00025495855,0.00008711852,0.0014113052,0.0010707232,0.0002722115,0.0018056777,0.00008168994],"about_ca_topic_score_codex":0.0006661733,"about_ca_topic_score_gemma":0.0013246818,"teacher_disagreement_score":0.03271831,"about_ca_system_score_codex":0.000754001,"about_ca_system_score_gemma":0.00066756894,"threshold_uncertainty_score":0.17303306},"labels":[],"label_agreement":null},{"id":"W2964134386","doi":"10.2147/vhrm.s206747","title":"<p>Prognostic implications of left ventricular strain by speckle-tracking echocardiography in the general population: a meta-analysis</p>","year":2019,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Imam Abdulrahman Bin Faisal University; University College London; British Heart Foundation; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Speckle tracking echocardiography; Internal medicine; Cardiology; Meta-analysis; Population; Clinical endpoint; Heart failure; Ejection fraction; Randomized controlled trial","score_opus":0.04906744595791978,"score_gpt":0.3275778628829054,"score_spread":0.2785104169249856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964134386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009221145,0.98519856,0.0017595676,0.0011283802,0.0005376626,0.0005912904,0.00095439993,0.00008863771,0.00052038475],"genre_scores_gemma":[0.4027073,0.5780986,0.006460306,0.004714933,0.0015733457,0.0031303328,0.0018174567,0.00014830672,0.0013494527],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99173975,0.0041273152,0.0019782896,0.00093725626,0.0008721131,0.00034531002],"domain_scores_gemma":[0.9757622,0.01787099,0.0035899635,0.0011684736,0.0013251057,0.0002831961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01722785,0.002839095,0.012325746,0.0040727598,0.00054729456,0.0037689714,0.001983356,0.0027754018,0.0049758605],"category_scores_gemma":[0.03480882,0.0013142645,0.043899696,0.0050911834,0.0008438512,0.0017866946,0.0016037746,0.002025051,0.00050730666],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002465012,0.000025399391,0.0058056456,0.20380403,0.77562505,0.00017271782,0.000067012166,0.00045554584,0.00029209562,0.00016254517,0.0012265762,0.00989837],"study_design_scores_gemma":[0.00076775363,0.00016565752,0.0048011043,0.012043846,0.97991073,0.00007312363,0.000024377017,0.00028957636,0.000118666125,0.000319154,0.001464113,0.000021930291],"about_ca_topic_score_codex":0.0049523073,"about_ca_topic_score_gemma":0.0067072455,"teacher_disagreement_score":0.01722785,"about_ca_system_score_codex":0.00174135,"about_ca_system_score_gemma":0.0026542319,"threshold_uncertainty_score":0.09111065},"labels":[],"label_agreement":null},{"id":"W2971102449","doi":"10.2147/vhrm.s209003","title":"<p>PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve</p>","year":2019,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Coronary flow reserve; Cardiology; Internal medicine; Mace; Coronary artery disease; Myocardial infarction; Fractional flow reserve; Angioplasty; Prospective cohort study; Angina; Canadian Cardiovascular Society; Percutaneous coronary intervention; Coronary angiography","score_opus":0.019195714221841825,"score_gpt":0.3031631327025165,"score_spread":0.28396741848067464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971102449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947349,0.002042962,0.00040986013,0.00023290694,0.00005902377,0.00042078365,0.0009691056,0.00002641265,0.0011040114],"genre_scores_gemma":[0.9923653,0.0010041955,0.0012735854,0.00043663857,0.0002727728,0.0008367545,0.0028403809,0.00001799418,0.0009523085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993599,0.00035829187,0.00003904073,0.00013716203,0.000046813057,0.000058714824],"domain_scores_gemma":[0.99889636,0.00022533584,0.0003389961,0.00013948495,0.000071518996,0.00032823932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019746847,0.0011529301,0.0011696545,0.0003234442,0.00031165613,0.0010622679,0.00047161247,0.0010118556,0.0014965151],"category_scores_gemma":[0.001299792,0.00055611937,0.00092341506,0.00050035276,0.00057805015,0.000841853,0.0006181411,0.0013106632,0.0004330061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40487632,0.004837393,0.5439414,0.0009427858,0.0052353446,0.0003370172,0.00017155164,0.0012714409,0.006821615,0.00045957242,0.0026101377,0.02849537],"study_design_scores_gemma":[0.13163076,0.08046202,0.77114064,0.00024722287,0.0059836325,0.00093346584,0.00013189722,0.0032949632,0.0017046368,0.0009637717,0.0034158411,0.0000911102],"about_ca_topic_score_codex":0.00033949173,"about_ca_topic_score_gemma":0.00050450204,"teacher_disagreement_score":0.0019746847,"about_ca_system_score_codex":0.00017693332,"about_ca_system_score_gemma":0.00032378483,"threshold_uncertainty_score":0.01044327},"labels":[],"label_agreement":null},{"id":"W2982946589","doi":"10.2147/vhrm.s204097","title":"<p>Periodontitis As A Risk Factor For Stroke: A Systematic Review And Meta-Analysis</p>","year":2019,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Periodontitis; Meta-analysis; Stroke (engine); Odds ratio; Critical appraisal; Risk factor; Cohort study; Systematic review; Cohort; Internal medicine; Case-control study; MEDLINE; Pathology; Alternative medicine","score_opus":0.06491950110310094,"score_gpt":0.3692482673531636,"score_spread":0.30432876625006267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982946589","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004026194,0.97375727,0.0033850744,0.004187961,0.0016679049,0.00772481,0.0036485833,0.00016471288,0.0014375128],"genre_scores_gemma":[0.07701165,0.8620379,0.021704845,0.0053311,0.0015762099,0.027462061,0.002651815,0.00012546762,0.002098917],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98365986,0.007297053,0.004568337,0.0009401685,0.0030569604,0.00047755372],"domain_scores_gemma":[0.9685241,0.019531867,0.0064779506,0.0010663319,0.004081803,0.0003180405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024409186,0.0027889793,0.013866668,0.011221618,0.0009247151,0.004602845,0.0021112603,0.0033402725,0.011192096],"category_scores_gemma":[0.08615728,0.0018711649,0.023883583,0.01130589,0.00087287556,0.0032925024,0.002071638,0.0024385392,0.0010264267],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006559547,0.000027164513,0.0016061284,0.88372934,0.084052846,0.00014979446,0.000119936514,0.00023131953,0.00029065646,0.0003951573,0.0050740265,0.023667622],"study_design_scores_gemma":[0.002186745,0.00054533884,0.0076522627,0.37661758,0.5902785,0.00033956126,0.00016222389,0.0008298095,0.0007606635,0.0014343791,0.019081749,0.00011126095],"about_ca_topic_score_codex":0.0051343082,"about_ca_topic_score_gemma":0.012555646,"teacher_disagreement_score":0.024409186,"about_ca_system_score_codex":0.0045262785,"about_ca_system_score_gemma":0.009085071,"threshold_uncertainty_score":0.12908965},"labels":[],"label_agreement":null},{"id":"W3087646696","doi":"10.2147/vhrm.s270751","title":"<p>Effect of Switching from Low-Dose Simvastatin to High-Dose Atorvastatin on Glucose Homeostasis and Cognitive Function in Type 2 Diabetes</p>","year":2020,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Faculty of Medicine Siriraj Hospital, Mahidol University; Mahidol University; Pfizer","keywords":"Medicine; Atorvastatin; Internal medicine; Glycated hemoglobin; Simvastatin; Type 2 diabetes; Glycemic; Endocrinology; Insulin resistance; Statin; Insulin; Glucose homeostasis; Diabetes mellitus","score_opus":0.008321686799131152,"score_gpt":0.24242821768342257,"score_spread":0.23410653088429142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087646696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990656,0.00029877457,0.0000437331,0.00006269713,0.0000387687,0.000089652036,0.000061430175,0.000011905888,0.0003273445],"genre_scores_gemma":[0.9981755,0.00030580797,0.00031392375,0.00016654472,0.000069172056,0.00016898118,0.00014881253,0.000003895043,0.0006474425],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99980515,0.0000707999,0.000023155653,0.000029695382,0.000015353415,0.000055915745],"domain_scores_gemma":[0.9994393,0.0001238831,0.000096222975,0.000050444432,0.0000325454,0.00025755563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007531339,0.0005052138,0.0014997227,0.0001555506,0.00022530461,0.00036447085,0.00032750214,0.00055085705,0.0024431357],"category_scores_gemma":[0.0007078599,0.00018001822,0.0010538403,0.00020443885,0.00040339617,0.00036447018,0.00023619752,0.0010499195,0.00027833995],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9253547,0.020405345,0.004144795,0.00027897142,0.00056698784,0.00009630859,0.000050466442,0.00045572332,0.009389973,0.000039929248,0.00036898948,0.038847804],"study_design_scores_gemma":[0.21851298,0.6725509,0.09450425,0.00009787964,0.0018796492,0.00015356613,0.0001045734,0.0026399079,0.008258769,0.0002059358,0.0010394079,0.000052211337],"about_ca_topic_score_codex":0.0015387755,"about_ca_topic_score_gemma":0.002339261,"teacher_disagreement_score":0.0024431357,"about_ca_system_score_codex":0.00044365515,"about_ca_system_score_gemma":0.0007450837,"threshold_uncertainty_score":0.008173108},"labels":[],"label_agreement":null},{"id":"W3097672180","doi":"10.2147/vhrm.s276477","title":"<p>Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age</p>","year":2020,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sociedad Española de Medicina de Familia y Comunitaria","keywords":"Medicine; Atrial fibrillation; Stroke (engine); Internal medicine; Incidence (geometry); Cohort; Population; Retrospective cohort study; Cohort study; Observational study; Montreal Cognitive Assessment; Cardiology; Pediatrics; Physical therapy; Cognitive impairment; Disease","score_opus":0.02045007389387467,"score_gpt":0.2928727124069839,"score_spread":0.27242263851310927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097672180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781954,0.000111197965,0.0012198921,0.000116948744,0.000021684962,0.000041411404,0.00047257988,0.000021094495,0.00017569886],"genre_scores_gemma":[0.9975967,0.00007769156,0.0011107008,0.00004018219,0.000030446132,0.00006384014,0.0008233932,0.0000070097926,0.00025008016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989735,0.00055154687,0.00005179502,0.00023276717,0.00010233706,0.00008816362],"domain_scores_gemma":[0.9962819,0.0015262995,0.0009233135,0.00055421423,0.00030086108,0.0004134367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006413121,0.0010207318,0.00073474646,0.0011142986,0.00044120516,0.0010805674,0.0011001952,0.0008538288,0.0012800839],"category_scores_gemma":[0.008913321,0.00056226086,0.001882141,0.0008388635,0.0004529756,0.0006497654,0.0007747285,0.0009010938,0.00038274372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063115434,0.00019604829,0.9955705,0.000020688163,0.0005011851,0.000067970184,0.00005970121,0.0013067526,0.00006350224,0.000049239767,0.0002701076,0.0012632277],"study_design_scores_gemma":[0.0005883322,0.0024438503,0.8952523,0.000058514634,0.00096860365,0.00066382234,0.00029101621,0.09846131,0.00018038943,0.0005458308,0.0005111519,0.000034776458],"about_ca_topic_score_codex":0.016159467,"about_ca_topic_score_gemma":0.008554669,"teacher_disagreement_score":0.016159467,"about_ca_system_score_codex":0.0007159734,"about_ca_system_score_gemma":0.0011205897,"threshold_uncertainty_score":0.033916235},"labels":[],"label_agreement":null},{"id":"W3198724880","doi":"10.2147/vhrm.s315248","title":"The Relationship Between Body Mass Index and In-Hospital Mortality in the Contemporary Era of an Acute Myocardial Infarction Management","year":2021,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Body mass index; Myocardial infarction; Logistic regression; Obesity; Internal medicine; Obesity paradox; Overweight","score_opus":0.019661668367810786,"score_gpt":0.2890876318159248,"score_spread":0.269425963448114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198724880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792886,0.00093635125,0.00009237899,0.0003213875,0.000018197703,0.0000037372552,0.00019356405,0.0000030550682,0.000502385],"genre_scores_gemma":[0.9993499,0.00030342006,0.00005552128,0.0000408126,0.000041839616,0.000003270572,0.00016062582,9.343834e-7,0.00004373378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962056,0.000093992094,0.000060249964,0.000056811048,0.000094710864,0.00007354982],"domain_scores_gemma":[0.99758077,0.00038654826,0.001465576,0.00007155748,0.00017570675,0.00031974708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007263511,0.0001864836,0.00023903597,0.00072057155,0.00024821778,0.00071034976,0.0003195175,0.0003689704,0.0012481463],"category_scores_gemma":[0.0035167665,0.00014049913,0.00025235486,0.0009848595,0.00022746588,0.00049167074,0.00043082662,0.0007575427,0.00016569669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036638212,0.000016504817,0.99906176,0.000006233627,0.000031181695,0.000027541852,0.000015168437,0.000023112743,0.00004681909,0.000016094216,0.00005540664,0.0006635156],"study_design_scores_gemma":[0.0000014407376,0.000025561929,0.9994435,0.000005481495,0.000020350575,0.00009961584,0.00006742834,0.00019551213,0.00001927261,0.000029787921,0.00009078849,0.0000012756465],"about_ca_topic_score_codex":0.0013725857,"about_ca_topic_score_gemma":0.002486622,"teacher_disagreement_score":0.0013725857,"about_ca_system_score_codex":0.0003293404,"about_ca_system_score_gemma":0.00028716933,"threshold_uncertainty_score":0.004175484},"labels":[],"label_agreement":null},{"id":"W3208260249","doi":"10.2147/vhrm.s333542","title":"Updating the VIVOPTIM Program for the Assessment of Cardiovascular Risk","year":2021,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Health Promotion and Cardiovascular Prevention","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Mutuelle Générale de l'Education Nationale","keywords":"Medicine; Risk assessment; Internal medicine","score_opus":0.017898067748323997,"score_gpt":0.3396835670574516,"score_spread":0.32178549930912764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208260249","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14722168,0.018464778,0.28063613,0.10740536,0.010228505,0.017050274,0.1655401,0.030135652,0.22331749],"genre_scores_gemma":[0.26687428,0.008957325,0.5466206,0.010894443,0.0054294528,0.02153473,0.101075545,0.0039040607,0.034709506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98430365,0.008014016,0.0017362974,0.00085457315,0.0046910774,0.00040038928],"domain_scores_gemma":[0.9275623,0.01659886,0.0068721087,0.0055041206,0.039400946,0.0040617483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029704712,0.0011712244,0.0010114016,0.0054589096,0.0007213074,0.0034409675,0.0025442094,0.0011189779,0.0076871817],"category_scores_gemma":[0.07501698,0.00062716927,0.001143492,0.0033005723,0.00042477768,0.0014963127,0.003352709,0.0028373285,0.0062126634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010501463,0.00061066437,0.16194378,0.00045516712,0.00027788855,0.00011279851,0.00031630046,0.0022107458,0.00081414776,0.0027793497,0.3428908,0.48653835],"study_design_scores_gemma":[0.0007545514,0.0006494694,0.36879262,0.0021812576,0.0003529259,0.00071105047,0.00040838186,0.015293909,0.0026871997,0.0038266017,0.6041699,0.00017214083],"about_ca_topic_score_codex":0.014961414,"about_ca_topic_score_gemma":0.013705196,"teacher_disagreement_score":0.029704712,"about_ca_system_score_codex":0.0021830986,"about_ca_system_score_gemma":0.006427786,"threshold_uncertainty_score":0.15709537},"labels":[],"label_agreement":null},{"id":"W3211546413","doi":"10.2147/vhrm.s334982","title":"An Association Between C-Reactive Protein Levels and the Occurrence of Cognitive Dysfunction After Heart Valve Replacement","year":2021,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Interquartile range; Postoperative cognitive dysfunction; Montreal Cognitive Assessment; C-reactive protein; Internal medicine; Proinflammatory cytokine; Cardiology; Systemic inflammation; Cognition; Valve replacement; Anesthesia; Inflammation; Dementia; Stenosis; Disease; Psychiatry","score_opus":0.012399568803335132,"score_gpt":0.2830306335509584,"score_spread":0.2706310647476233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211546413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942774,0.00023436104,0.00006023265,0.00002332325,0.0000073197784,0.0000034756165,0.000039565406,0.000001899152,0.00020204978],"genre_scores_gemma":[0.99982893,0.000041931988,0.00003922449,0.000007521491,0.000008855892,0.0000024922133,0.00003988252,3.9539822e-7,0.000030694162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958056,0.00008021933,0.00006934715,0.00006658806,0.000111003326,0.00009217563],"domain_scores_gemma":[0.99673223,0.0008563601,0.0014001635,0.00012839955,0.00040447572,0.00047833056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061765936,0.0003078446,0.00030505098,0.00054626766,0.0003567383,0.0004676005,0.00021613626,0.00037456417,0.0010901681],"category_scores_gemma":[0.0034733948,0.0001385978,0.00034037887,0.0005919856,0.00031680698,0.0002009601,0.00031024203,0.0008003882,0.0001285242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019576172,0.000048077167,0.9984383,0.000009047407,0.00003566511,0.00013572063,0.000027886055,0.000034160945,0.00025712623,0.000007608008,0.000028333843,0.00078237284],"study_design_scores_gemma":[0.000007745925,0.00023147557,0.9987557,0.000004772017,0.000030949148,0.0005366567,0.000055473345,0.00018360939,0.000117307565,0.000020130854,0.00005200421,0.000004215952],"about_ca_topic_score_codex":0.0010064926,"about_ca_topic_score_gemma":0.0011069662,"teacher_disagreement_score":0.0010901681,"about_ca_system_score_codex":0.0002597943,"about_ca_system_score_gemma":0.0004112657,"threshold_uncertainty_score":0.0036469698},"labels":[],"label_agreement":null},{"id":"W4247685545","doi":"10.2147/vhrm.s2347","title":"Effect of short-term lycopene supplementation and postprandial dyslipidemia on plasma antioxidants and biomarkers of endothelial health in young, healthy individuals","year":2008,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"University of Waterloo; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Medicine; Dyslipidemia; Postprandial; Lycopene; Cardiovascular health; Internal medicine; Endothelial dysfunction; Endocrinology; Obesity; Antioxidant; Disease; Insulin; Biochemistry","score_opus":0.013477567764619074,"score_gpt":0.3068498764235746,"score_spread":0.2933723086589555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247685545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999491,0.0003683864,0.000027169273,0.00001165691,0.000005240499,0.000005791572,0.000024661373,0.0000014634774,0.00006461918],"genre_scores_gemma":[0.9990343,0.0002143192,0.00018834136,0.00007458831,0.000012539451,0.000021628903,0.000086729895,0.0000013468688,0.00036615846],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999006,0.000037085654,0.000009983983,0.000021814989,0.0000143604075,0.000016185399],"domain_scores_gemma":[0.9996282,0.00007867788,0.000092688744,0.00002625798,0.000030939256,0.00014320553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041735955,0.00031145028,0.000504241,0.00016194617,0.0001806298,0.00029110265,0.00009627549,0.00048555073,0.0007527866],"category_scores_gemma":[0.00046025633,0.00022928012,0.00023800398,0.00009820966,0.00014935769,0.00020200825,0.0001770631,0.0004096467,0.00012566075],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11945918,0.0071083414,0.5040017,0.00043735164,0.0010877748,0.0012421752,0.0006689154,0.00019667343,0.33598852,0.000065805325,0.00040647734,0.029337155],"study_design_scores_gemma":[0.00037733023,0.017681738,0.9772388,0.0000107588285,0.00019448077,0.00031508066,0.00011514541,0.000170366,0.0036119542,0.000021918746,0.0002546957,0.000007860038],"about_ca_topic_score_codex":0.0006438964,"about_ca_topic_score_gemma":0.001295385,"teacher_disagreement_score":0.0007527866,"about_ca_system_score_codex":0.000105286614,"about_ca_system_score_gemma":0.00012201578,"threshold_uncertainty_score":0.0025182962},"labels":[],"label_agreement":null},{"id":"W4281694823","doi":"10.2147/vhrm.s274857","title":"Bidirectional Ventricular Tachycardia: Challenges and Solutions","year":2022,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Ventricular tachycardia; Tachycardia; Intensive care medicine","score_opus":0.039518305783862825,"score_gpt":0.30485671037866763,"score_spread":0.2653384045948048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281694823","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010614343,0.9940929,0.000293463,0.0035567707,0.0008273542,0.0000050884555,0.000015633614,0.000014360733,0.0010882737],"genre_scores_gemma":[0.0009985914,0.99514776,0.00037246675,0.0016038169,0.0013188537,0.00000865021,0.000026320897,0.0000035683072,0.0005200489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996455,0.000091678645,0.0000740922,0.000057542205,0.0001023072,0.00002881203],"domain_scores_gemma":[0.9989122,0.0006052566,0.00010743561,0.000027181313,0.00027508393,0.00007292385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011606778,0.0006527341,0.0016090898,0.0013605542,0.00037128685,0.0017424438,0.000944863,0.0021257792,0.0041110246],"category_scores_gemma":[0.002022828,0.00023949819,0.00073327654,0.0008667137,0.0006399333,0.002883345,0.0010149925,0.0032606218,0.0019847013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000730735,0.00007627264,0.00023988321,0.019348554,0.00011008869,0.00068286946,0.00015805793,0.0003440377,0.0008221522,0.012543326,0.061400063,0.90420157],"study_design_scores_gemma":[0.000026154912,0.000087763736,0.00042609285,0.012384447,0.00013642399,0.0036932249,0.000271064,0.00019757445,0.00017884944,0.010043066,0.9725185,0.00003689138],"about_ca_topic_score_codex":0.00068069284,"about_ca_topic_score_gemma":0.001216545,"teacher_disagreement_score":0.0041110246,"about_ca_system_score_codex":0.00052611216,"about_ca_system_score_gemma":0.0017208584,"threshold_uncertainty_score":0.0137527585},"labels":[],"label_agreement":null},{"id":"W4304807925","doi":"10.2147/vhrm.s271411","title":"Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis","year":2022,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Edoxaban; Rivaroxaban; Apixaban; Cancer; Internal medicine; Low molecular weight heparin; Intensive care medicine; Population; Thrombosis; Warfarin; Atrial fibrillation","score_opus":0.07451950353282594,"score_gpt":0.4001270008317832,"score_spread":0.32560749729895727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304807925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056991255,0.9895214,0.00042650948,0.003629115,0.0013277224,0.000047661295,0.00019370262,0.000025095434,0.004258988],"genre_scores_gemma":[0.010793235,0.9777215,0.0014600238,0.0037739081,0.003035308,0.00010704835,0.0006328155,0.000009440008,0.002466802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977424,0.00076358835,0.00048428902,0.00016288758,0.0007616545,0.00008512739],"domain_scores_gemma":[0.99703443,0.0011317391,0.0008046775,0.00010799238,0.0007953729,0.000125827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017595012,0.00040299486,0.00085427804,0.0015433524,0.00029927975,0.00086973904,0.00037604125,0.0008411658,0.0064523257],"category_scores_gemma":[0.005389941,0.000103308004,0.0011558237,0.001326496,0.00031458488,0.0006786347,0.0004619135,0.0018137125,0.0018615739],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042362337,0.000113060254,0.00094355934,0.02256592,0.0005711092,0.00018746915,0.00007133702,0.00011524862,0.0009159309,0.004415905,0.09438756,0.8752892],"study_design_scores_gemma":[0.0005204712,0.0005760968,0.0048731286,0.016750064,0.0010836477,0.0022990946,0.0000647079,0.00014502408,0.0009029369,0.003306864,0.9694374,0.00004045897],"about_ca_topic_score_codex":0.0010224603,"about_ca_topic_score_gemma":0.0017844186,"teacher_disagreement_score":0.0064523257,"about_ca_system_score_codex":0.0005203563,"about_ca_system_score_gemma":0.0019980483,"threshold_uncertainty_score":0.021585166},"labels":[],"label_agreement":null},{"id":"W4318263103","doi":"10.2147/vhrm.s394134","title":"Elevated Lp(a) Levels Correlate with Severe and Multiple Coronary Artery Stenotic Lesions","year":2023,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Coronary artery disease; Lipoprotein(a); Stenosis; Risk factor; Coronary arteries; Artery; Logistic regression; Cholesterol; Lipoprotein","score_opus":0.018674864920282724,"score_gpt":0.24680573218995366,"score_spread":0.22813086726967094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318263103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907506,0.00031058956,0.00020338487,0.000044892648,0.000007372827,0.0000041480143,0.000077309494,0.0000047233225,0.00027250548],"genre_scores_gemma":[0.9994516,0.000091342175,0.00017907361,0.000015317439,0.000022196085,0.000004095898,0.00008780078,0.0000018557652,0.00014676785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963737,0.00009677928,0.00006999294,0.00008785237,0.00006377556,0.000044337103],"domain_scores_gemma":[0.9973175,0.0006806372,0.0013660348,0.00014823154,0.00012319993,0.00036448025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045818882,0.0003397927,0.00034111468,0.00055313966,0.0003483973,0.0005084952,0.0001828151,0.00053645583,0.0036996838],"category_scores_gemma":[0.0018306213,0.00022732538,0.0002963168,0.00064605364,0.000320062,0.00020190234,0.0003595414,0.00080050307,0.00039210776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027823073,0.00004301104,0.9965144,0.000017589973,0.000056971134,0.00030155727,0.000035194927,0.000029614104,0.0013256688,0.000019983117,0.00004497488,0.0013328445],"study_design_scores_gemma":[0.000009420732,0.00017570083,0.99724555,0.000005893196,0.000054248096,0.0017976636,0.00006637096,0.00013863442,0.0002914866,0.000072270144,0.00013880375,0.000004046323],"about_ca_topic_score_codex":0.0002856195,"about_ca_topic_score_gemma":0.0003826445,"teacher_disagreement_score":0.0036996838,"about_ca_system_score_codex":0.00009475329,"about_ca_system_score_gemma":0.00015199374,"threshold_uncertainty_score":0.012376726},"labels":[],"label_agreement":null},{"id":"W4320912911","doi":"10.2147/vhrm.s394695","title":"Genetic Variants in PHACTR1 & LPL Mediate Restenosis Risk in Coronary Artery Patients","year":2023,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Restenosis; Genetics; Biology","score_opus":0.017022531129938324,"score_gpt":0.27955084929346075,"score_spread":0.2625283181635224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320912911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981078,0.00054819643,0.00035489467,0.000083411556,0.0000132731175,0.000009669981,0.00039281146,0.000010958518,0.00047895638],"genre_scores_gemma":[0.99896455,0.00013294909,0.00029728777,0.000027067108,0.000027418937,0.0000121997045,0.0002334734,0.000004758784,0.00030034437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954504,0.00017697857,0.000048423688,0.00012217468,0.000056135566,0.000051284813],"domain_scores_gemma":[0.99868304,0.00049490604,0.0005311514,0.00009255634,0.00006231546,0.00013609143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007605271,0.0004903315,0.00035508437,0.0005808685,0.00032778672,0.00063207274,0.00040241386,0.0005976446,0.0040639765],"category_scores_gemma":[0.0022317192,0.00022868889,0.0005484988,0.0008529092,0.00029054453,0.00018727279,0.00026052975,0.0004772732,0.00043774984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015335283,0.000115804825,0.9907184,0.000037562346,0.00042577542,0.0005790716,0.00010094879,0.00016005653,0.0027634078,0.00010363466,0.00028996094,0.0031717953],"study_design_scores_gemma":[0.00008754195,0.00023831389,0.9958383,0.00002024816,0.00038677218,0.0011878083,0.00008234526,0.0009756208,0.00060459593,0.0002027186,0.000366961,0.0000088182405],"about_ca_topic_score_codex":0.0010837999,"about_ca_topic_score_gemma":0.00081608735,"teacher_disagreement_score":0.0040639765,"about_ca_system_score_codex":0.00012569562,"about_ca_system_score_gemma":0.00015661202,"threshold_uncertainty_score":0.013595343},"labels":[],"label_agreement":null},{"id":"W4367060120","doi":"10.2147/vhrm.s405357","title":"Prevalence and Associated Factors of Cognitive Impairment Among Stroke Survivors at Comprehensive Specialized Hospitals in Northwest Ethiopia: Multi-Centered Cross-Sectional Study","year":2023,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"College of Medicine and Health Sciences, University of Gondar; University of Gondar","keywords":"Medicine; Stroke (engine); Cross-sectional study; Logistic regression; Cognition; Descriptive statistics; Montreal Cognitive Assessment; Multivariate analysis; Activities of daily living; Cognitive impairment; Physical therapy; Gerontology; Psychiatry; Internal medicine","score_opus":0.026091361156293576,"score_gpt":0.31299699619715327,"score_spread":0.2869056350408597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367060120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99970764,0.000051758103,0.00002716003,0.000010295806,0.0000012020229,0.000010910793,0.00012400644,5.6821517e-7,0.00006644312],"genre_scores_gemma":[0.9995449,0.00009459032,0.00009869655,0.000025876356,0.0000033257838,0.000020114125,0.00014802719,3.5693503e-7,0.00006402029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996381,0.00010281722,0.000060059065,0.000068370566,0.000059601683,0.000071105795],"domain_scores_gemma":[0.99931717,0.00012719298,0.0002710442,0.000033976256,0.00010695442,0.00014369894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008442574,0.00024162295,0.00033140212,0.0008560581,0.00053072727,0.00055965676,0.0002516516,0.00033853733,0.000795637],"category_scores_gemma":[0.0009833529,0.0003555881,0.0002925486,0.0008656564,0.00019183347,0.00040362426,0.0003126283,0.00029962236,0.00013299374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024398245,0.00007060318,0.9990126,0.000010765323,0.000021520495,0.00008292244,0.00021140501,0.000011539994,0.00011560896,0.0000062026984,0.00003765955,0.00039487015],"study_design_scores_gemma":[0.000004190567,0.0001286821,0.9978173,0.000013406706,0.000019755431,0.00031110455,0.0014832338,0.00008036272,0.000044356813,0.000008138087,0.00008568562,0.0000039598717],"about_ca_topic_score_codex":0.0061317915,"about_ca_topic_score_gemma":0.0090409545,"teacher_disagreement_score":0.0061317915,"about_ca_system_score_codex":0.0003636563,"about_ca_system_score_gemma":0.0005134976,"threshold_uncertainty_score":0.01219219},"labels":[],"label_agreement":null},{"id":"W4390277074","doi":"10.2147/vhrm.s442108","title":"Prevalence and Factors Associated with Hypertension Among HIV Positive Patients on Antiretroviral Therapy: A Hospital-Based Cross-Sectional Study in Rwanda","year":2023,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre for Interdisciplinary Research in Rehabilitation","funders":"","keywords":"Medicine; Cross-sectional study; Odds ratio; Logistic regression; Confidence interval; Population; Antiretroviral therapy; Statistical significance; Odds; Public health; Human immunodeficiency virus (HIV); Internal medicine; Demography; Pediatrics; Viral load; Environmental health; Immunology","score_opus":0.017157254318637547,"score_gpt":0.2822261728771368,"score_spread":0.26506891855849923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390277074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99948174,0.00013524365,0.000036749345,0.00002847995,0.0000040895266,0.000015793552,0.0001334185,0.0000014921843,0.00016316313],"genre_scores_gemma":[0.99963176,0.00012010414,0.000058879858,0.000022407687,0.000005972463,0.000017218428,0.000083278406,6.2111815e-7,0.000059752754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994874,0.00020535095,0.00006526714,0.00007965324,0.00006634656,0.00009593668],"domain_scores_gemma":[0.9992581,0.00017787793,0.00031691664,0.000050198614,0.000068728375,0.00012824046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006465785,0.0002457225,0.00033510724,0.0007815996,0.00049687305,0.0006065628,0.00029823015,0.00041337736,0.0010972954],"category_scores_gemma":[0.0014878382,0.0005151908,0.00034390914,0.0008955952,0.0003642753,0.0005634693,0.0004425786,0.000527876,0.00024099025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019449371,0.00004941979,0.99911886,0.000010866207,0.00001535182,0.000083790714,0.00019692686,0.0000062450276,0.00013675008,0.0000053518534,0.00003501311,0.00032206334],"study_design_scores_gemma":[0.0000038397156,0.00013762245,0.99856156,0.000014069494,0.000016818774,0.00034841947,0.0007551743,0.00004827967,0.000024862655,0.0000049960977,0.000081820515,0.0000026766425],"about_ca_topic_score_codex":0.005477264,"about_ca_topic_score_gemma":0.007743752,"teacher_disagreement_score":0.005477264,"about_ca_system_score_codex":0.00029698454,"about_ca_system_score_gemma":0.00043810447,"threshold_uncertainty_score":0.010890722},"labels":[],"label_agreement":null},{"id":"W4399897968","doi":"10.2147/vhrm.s391808","title":"Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights","year":2024,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Weill Cornell Medicine - Qatar; Weill Cornell Medical College","keywords":"Medicine; Atrial fibrillation; Metformin; Internal medicine; Repurposing; Diabetes mellitus; Cardiology; Current (fluid); Intensive care medicine; Insulin; Endocrinology","score_opus":0.01638758597438475,"score_gpt":0.29983318237722734,"score_spread":0.2834455964028426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399897968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016571867,0.9988519,0.00007670427,0.00028203544,0.0001349656,0.000007597352,0.000016193577,0.0000039498527,0.00046083852],"genre_scores_gemma":[0.00070455746,0.99849594,0.00016229473,0.00026777023,0.00016080032,0.000010693692,0.000020360774,0.0000012070926,0.0001763207],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997002,0.000059967213,0.00008375092,0.000044059623,0.00009125457,0.000020725261],"domain_scores_gemma":[0.999488,0.00027104246,0.00009844596,0.000011029016,0.00010614672,0.000025382622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006726717,0.00049784494,0.0011144531,0.0016540485,0.00018881203,0.0011070531,0.0006807467,0.0007144984,0.002761374],"category_scores_gemma":[0.0010502718,0.00023442757,0.00077918894,0.0016152506,0.00029623913,0.0011497551,0.0004791595,0.001245161,0.0009124533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001258024,0.00008605838,0.00021863483,0.053634968,0.00018017732,0.00033391398,0.00021163023,0.00030008896,0.0019941062,0.0031618967,0.02081684,0.91893595],"study_design_scores_gemma":[0.000037038364,0.0002415177,0.0010033598,0.012041644,0.0003612698,0.0010714456,0.00010910834,0.00012226947,0.00042764397,0.002257762,0.9823017,0.000025364832],"about_ca_topic_score_codex":0.0006050887,"about_ca_topic_score_gemma":0.0012083258,"teacher_disagreement_score":0.002761374,"about_ca_system_score_codex":0.0003360962,"about_ca_system_score_gemma":0.0008707096,"threshold_uncertainty_score":0.009237707},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4401554217","doi":"10.2147/vhrm.s431612","title":"Interobserver Variability of Coronary Stenosis Characterized by Coronary Angiography: A Single-Center (Toronto General Hospital) Retrospective Chart Review by Staff Cardiologists","year":2024,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Coronary angiography; Retrospective cohort study; Stenosis; Single Center; Chart; General hospital; Cardiology; Radiology; Internal medicine; Emergency medicine; Myocardial infarction","score_opus":0.008375683840370924,"score_gpt":0.2534694073255018,"score_spread":0.2450937234851309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401554217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972965,0.0013051662,0.00034674842,0.00004821069,0.000011186144,0.000073254494,0.0005300676,0.0000109346465,0.00037796664],"genre_scores_gemma":[0.9990921,0.00028224805,0.0001396049,0.000025107767,0.00001560467,0.00003578764,0.00035612745,0.0000033996978,0.000049972674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932413,0.001475998,0.0012829914,0.0010208493,0.0025521875,0.0004266814],"domain_scores_gemma":[0.9747552,0.006063054,0.011395172,0.001545909,0.0051715164,0.0010692336],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0035860876,0.0003304358,0.0006206009,0.003373155,0.00097552425,0.0011038223,0.0006006274,0.00044401665,0.0009266249],"category_scores_gemma":[0.010274759,0.0005471608,0.00043141306,0.0034590636,0.0011143755,0.0005862832,0.000777553,0.00033517784,0.00018251203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046168374,0.000009076089,0.99761283,0.000050997016,0.00003285488,0.00019650314,0.00065475557,0.000016312377,0.000193111,0.000005846175,0.000101533864,0.0010799858],"study_design_scores_gemma":[0.0000036498466,0.000069256734,0.9981706,0.000026246811,0.00003755514,0.0005667873,0.0007584879,0.00007015756,0.00013698598,0.0000037826903,0.00014930479,0.000007114969],"about_ca_topic_score_codex":0.054475024,"about_ca_topic_score_gemma":0.063566655,"teacher_disagreement_score":0.9964139,"about_ca_system_score_codex":0.002797082,"about_ca_system_score_gemma":0.002138133,"threshold_uncertainty_score":0.108315885},"labels":[],"label_agreement":null},{"id":"W4415916735","doi":"10.2147/vhrm.s559424","title":"The Effectiveness and Safety of Cardiac Shock Wave Therapy in the Treatment of Ischemic Heart Disease with Refractory Angina Pectoris","year":2025,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Pain Management and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Refractory (planetary science); Angina; Disease; Shock (circulatory); Heart failure; Ischemia; Cardiac function curve","score_opus":0.007254642037654335,"score_gpt":0.25988910567737605,"score_spread":0.2526344636397217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415916735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975649,0.0019191026,0.00006175682,0.000046843736,0.000012426129,0.00003961686,0.00004297102,0.0000023530674,0.0003100033],"genre_scores_gemma":[0.99895227,0.00060089654,0.000094172065,0.00007124056,0.0000635776,0.000029583169,0.000087012144,6.1018255e-7,0.000100671205],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968636,0.00014011422,0.000039249353,0.00003617848,0.00006309002,0.00003511612],"domain_scores_gemma":[0.9993457,0.00019297254,0.0002775115,0.000026881864,0.00004561509,0.00011132557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009752468,0.0001922737,0.00048730057,0.00022020539,0.00013935874,0.00024884194,0.00014494888,0.00027154837,0.00073737203],"category_scores_gemma":[0.0009944859,0.00006141231,0.00033063686,0.0001753987,0.00020284901,0.00018006611,0.00014825418,0.0003984314,0.000079044294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17165789,0.01710335,0.38861042,0.0011613928,0.0018044668,0.00047352954,0.0002558247,0.0009422097,0.035280272,0.00012849428,0.0006123289,0.3819699],"study_design_scores_gemma":[0.010140036,0.25037518,0.7326253,0.000099255856,0.00078849855,0.00052024156,0.00012680123,0.000893445,0.002989011,0.000085570915,0.0013378664,0.000018717652],"about_ca_topic_score_codex":0.00019427946,"about_ca_topic_score_gemma":0.0003334625,"teacher_disagreement_score":0.0009752468,"about_ca_system_score_codex":0.00015513909,"about_ca_system_score_gemma":0.00022890682,"threshold_uncertainty_score":0.005157709},"labels":[],"label_agreement":null}]}